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Abstract
The mouse organ of Corti, housed inside the cochlea, contains hair cells and supporting
cells that transduce sound into electrical signals. These cells develop in two main steps: pro-
genitor specification followed by differentiation. Fibroblast Growth Factor (FGF) signaling is
important in this developmental pathway, as deletion of FGF receptor 1 (Fgfr1) or its ligand,
Fgf20, leads to the loss of hair cells and supporting cells from the organ of Corti. However,
whether FGF20-FGFR1 signaling is required during specification or differentiation, and how
it interacts with the transcription factor Sox2, also important for hair cell and supporting cell
development, has been a topic of debate. Here, we show that while FGF20-FGFR1 signal-
ing functions during progenitor differentiation, FGFR1 has an FGF20-independent, Sox2-
dependent role in specification. We also show that a combination of reduction in Sox2
expression and Fgf20 deletion recapitulates the Fgfr1-deletion phenotype. Furthermore, we
uncovered a strong genetic interaction between Sox2 and Fgf20, especially in regulating the
development of hair cells and supporting cells towards the basal end and the outer compart-
ment of the cochlea. To explain this genetic interaction and its effects on the basal end of
the cochlea, we provide evidence that decreased Sox2 expression delays specification,
which begins at the apex of the cochlea and progresses towards the base, while Fgf20-dele-
tion results in premature onset of differentiation, which begins near the base of the cochlea
and progresses towards the apex. Thereby, Sox2 and Fgf20 interact to ensure that specifi-
cation occurs before differentiation towards the cochlear base. These findings reveal an
intricate developmental program regulating organ of Corti development along the basal-api-
cal axis of the cochlea.
Author summary
The mammalian cochlea contains the organ of Corti, a specialized sensory epithelium
populated by hair cells and supporting cells that detect sound. Hair cells are susceptible to
injury by noise, toxins, and other insults. In mammals, hair cells cannot be regenerated
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after injury, resulting in permanent hearing loss. Understanding genetic pathways that
regulate hair cell development in the mammalian organ of Corti will help in developing
methods to regenerate hair cells to treat hearing loss. Many genes are essential for hair cell
and supporting cell development in the mouse organ of Corti. Among these are Sox2,
Fgfr1, and Fgf20. Here, we investigate the relationship between these three genes to further
define their roles in development. Interestingly, we found that Sox2 and Fgf20 interact to
affect hair cell and supporting cell development in a spatially-graded manner. We found
that cells toward the outer compartment and the base of the cochlea are more strongly
affected by the loss of Sox2 and Fgf20. We provide evidence that this spatially-graded effect
can be partially explained by the roles of the two genes in the precise timing of two
sequential stages of organ of Corti development, specification and differentiation.
Introduction
The inner ear contains six sensory organs required for the senses of hearing and balance. The
cochlea, a snail-like coiled duct, is the auditory organ. It contains specialized sensory epithelia,
called the organ of Corti, composed of hair cells (HCs) and supporting cells (SCs). In mam-
mals, this sensory epithelium is elegantly patterned, with one row of inner hair cells (IHCs)
and three rows of outer hair cells (OHCs), separated by two rows of pillar cells forming the
tunnel of Corti. Each row of OHCs is associated with a row of supporting cells called Deiters’
cells. Here, we refer to pillar cells and Deiters’ cells collectively as SCs.
Organ of Corti development has been described as occurring in two main steps: prosensory
specification and differentiation [1]. During prosensory specification, proliferative progenitors
at the floor of the developing cochlear duct are specified and then exit the cell cycle to form the
postmitotic prosensory domain. Here, we define specification to be a process that makes pro-
genitors competent to differentiate. We also use cell cycle exit as a marker for specified cells in
the prosensory domain (prosensory cells). During differentiation, prosensory cells differentiate
into both HCs and SCs [2]. Interestingly, cell cycle exit, marking the completion of specifica-
tion, and initiation of differentiation occur in waves that travel in opposite directions along the
length of the cochlear duct. At around embryonic day 12.5 (E12.5) in the mouse, progenitors
begin to exit the cell cycle and express the cyclin-dependent kinase inhibitor CDKN1B
(p27Kip1) in a wave that begins at the apex of the cochlea (the cochlear tip) and reaches the
base of the cochlea by around E14.5 [3,4]. Afterwards, the specified prosensory cells begin dif-
ferentiating into HCs and SCs in a second wave that begins at the mid-base at around E13.5,
and spreads quickly to the rest of the base and to the apex over the next few days [1]. Thus,
while prosensory specification occurs in an apical-to-basal gradient, differentiation occurs in a
basal-to-apical gradient. Notably, while the basal end of the cochlear duct differentiates imme-
diately after prosensory specification, the apical end has a longer time between specification
and differentiation, providing a larger “temporal buffer” for apical development. The spiral
ganglion, containing neurons that synapse with HCs, has been shown to be important for this
delay in apical differentiation, via inhibitory Sonic Hedgehog (SHH) signaling [5–8].
The transcription factor Sox2 is one of the earliest markers of prosensory cells [9,10]. Mice
with specific Sox2 hypomorphic mutations that affect inner ear expression have hearing
impairment due to decreased HC and SC number, while mice with inner ear-specific Sox2 null
mutations are completely deaf and have no HCs or SCs [11,12]. Genetic experiments show
that Sox2 is both necessary and sufficient for prosensory specification. Absence of Sox2 expres-
sion leads to the loss of Cdkn1b expression at E14, a marker for the prosensory domain [12],
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while ectopic Sox2 expression in cochlear nonsensory epithelium can induce ectopic sensory
patches [13–15].
The Fibroblast Growth Factor (FGF) signaling pathway also plays vital roles in organ of
Corti development [16]. Studies utilizing cochlear explants showed that inhibition of FGF sig-
naling prior to and during stages of HC and SC differentiation results in decreased HC and SC
number [17]. Signaling through FGF receptor 1 (FGFR1), in particular, is essential during this
process. Conditional deletion of Fgfr1 (Fgfr1-CKO) in the developing cochlear epithelium
resulted in dramatically reduced HC and SC number [18–20]. This has been attributed to
decreased Sox2 expression in the prosensory domain of Fgfr1-CKO mice, leading to a defect in
prosensory specification [19].
FGF20 has been hypothesized to be the FGFR1 ligand during organ of Corti development.
Both in vitro inhibition of FGF20 with an anti-FGF20 antibody [17] and in vivo knockout of
Fgf20 (Fgf20-KO) [21] led to decreased HC and SC number, similar to the Fgfr1-CKO pheno-
type. However, the Fgf20-KO phenotype is clearly not as severe as that of Fgfr1-CKO. Almost
all OHCs and some IHCs are missing in Fgfr1-CKO mice [19], while only 2/3 of OHCs are
missing in Fgf20-KO mice, without any loss of IHCs [21]. This suggests that another FGF
ligand may be redundant with and compensating for the loss of FGF20, the identity of which is
currently unknown.
Another difference between Fgfr1-CKO and Fgf20-KO mice is the proposed mechanism
accounting for the decrease in HCs and SCs. Interestingly, unlike in Fgfr1-CKO mice, Sox2
expression in the prosensory domain is not disrupted in Fgf20-KO mice [19,21]. Rather,
FGF20 seems to function during HC and SC differentiation. These differences between the
Fgfr1-CKO and Fgf20-KO phenotypes and their relationship with Sox2 suggest that FGF20/
FGFR1 signaling has a more complex and as yet unexplained role during organ of Corti
development.
Here, we hypothesize that FGFR1 signaling has functions in both steps of organ of Corti
development: an earlier role in prosensory specification that involves Sox2, and a later role in
the initiation of differentiation. We provide evidence that FGF20 regulates differentiation but
not specification. Moreover, while Fgfr1 functions upstream of Sox2, Fgf20 is downstream of
Sox2. We further show that Sox2 and Fgf20 genetically interact during organ of Corti develop-
ment. Interestingly, downregulation of both genes leads to the loss of HCs and SCs preferen-
tially towards the outer compartment and the basal end of the cochlear duct. To explain the
more severe basal phenotype, we provide evidence that Sox2 regulates the timing of prosensory
specification, while Fgf20 regulates the timing of differentiation. As these two steps occur
along a developmental pathway, we hypothesize that prosensory specification must occur
prior to differentiation. In Sox2 hypomorphic mice, prosensory specification is delayed, while
in Fgf20-KO mice, the onset of differentiation occurs prematurely. When combined, these two
defects led to differentiation attempting to initiate prior to the completion of specification
towards the basal end of the cochlear duct. These results define unique functions of and com-
plex interactions among FGF20, FGFR1, and Sox2 during organ of Corti development and
highlight the potential importance of the timing of specification and differentiation along dif-
ferent regions of the cochlear duct.
Results
The Fgf20-KO cochlear phenotype is less severe than the Fgfr1-CKO
phenotype
Previous studies showed that deletion of Fgf20 leads to a loss of two thirds of OHCs in the
mouse organ of Corti [21], while conditional deletion of Fgfr1 from the cochlear epithelium
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leads to a loss of almost all OHCs and some IHCs [19,20]. To rule out the effect of genetic back-
ground accounting for these differences, we generated Fgf20 knockout (Fgf20-KO: Fgf20-/-) and
Fgfr1 conditional knockout (Fgfr1-CKO: Foxg1Cre/+; Fgfr1flox/-) mice along with littermate con-
trols (Fgf20+/- for Fgf20-KO and Fgfr1flox/+, Fgfr1flox/-, and Foxg1Cre/+;Fgfr1flox/+ for Fgfr1-CKO)
on a mixed C57BL/6J and 129X1/SvJ genetic background. Fgf20-KO and Fgfr1-CKO mice were
generated in separate matings; therefore, some genetic background differences could persist.
Foxg1Cre targets most of the otic vesicle as early as E9.5 [22] and has been used in other studies
to conditionally delete Fgfr1 [18–20]. In the Fgf20- allele, exon 1 of Fgf20 is replaced by a
sequence encoding a GFP-Cre fusion protein [18]. We also refer to this null allele as Fgf20Cre.
We examined the cochleae at P0 (Fig 1A and 1B) and quantified the length of the cochlear
duct and the total number of IHCs, OHCs, and SCs (Fig 1C–1F), as well as the number of cells
along the basal, middle, and apical turns of the cochlear duct (S1A–S1C Fig). Refer to Fig 1G
for the positions of basal, middle, and apical turns along the cochlear duct. We identified HCs
based on Phalloidin labeling and SCs based on Prox1/Sox2 labeling. IHCs and OHCs were dis-
tinguished based on location relative to p75NTR-labeled inner pillar cells (IHCs are neural, or
towards the center of the coiled duct; OHCs are abneural).
In both Fgf20-KO and Fgfr1-CKO cochleae, there were gaps in the sensory epithelium that
lacked HCs and SCs along the entire cochlear duct. Quantitatively, Fgf20-KO cochleae had a
6% reduction in cochlear length compared to control (Fgf20+/-) cochleae, while Fgfr1-CKO
cochleae had a 28% reduction compared to control (Fgfr1Cre/+;Fgfr1flox/+). Fgf20-KO did not
have a significant reduction in the number of IHCs, while Fgfr1-CKO cochleae had a 40%
reduction. Fgf20-KO cochleae only had a 76% reduction in the number of OHCs, while Fgfr1-
CKO cochleae had almost a complete lack of OHCs, a 97% reduction. For SCs, Fgf20-KO
cochleae had a 59% reduction, while Fgfr1-CKO cochleae had an 84% reduction. These pat-
terns persisted when HC and SC numbers were normalized to cochlear length. These results
were all consistent with previous studies [19,21] and showed that the Fgfr1-CKO phenotype is
more severe than the Fgf20-KO phenotype in cochlear length and in the number of HCs and
SCs. We hypothesize that during organ of Corti development, there is an additional FGFR1
ligand that is partially redundant with FGF20.
Notably, while the total number of IHCs was decreased in Fgfr1-CKO cochleae, the
decrease was only observed in the basal and middle turns of the cochlea, not in the apical turn
(S1A Fig). In addition, the number of IHCs normalized to cochlear length was slightly
increased in Fgf20-KO cochleae (Fig 1D), and this increase was only prominent in the middle
and apical turns of the cochlea, but not in the basal turn (S1A Fig). The increase in IHCs could
be explained by the shortened cochlear duct length in Fgf20-KO mice. No such basal/middle/
apical turn discrepancies existed in the number of OHCs or SCs in either genotype (S1B and
S1C Fig).
Our previous studies also noted that the apical tip of Fgf20-KO cochleae has delayed differ-
entiation relative to control at E16.5 and P0, but catches up by P7 [21]. We confirmed this
result, finding that at P0 in control cochleae, sensory epithelium at the apical tip has begun to
differentiate, based on phalloidin and p75NTR expression, while in Fgf20-KO cochleae, there
was no sign of differentiation at the apical tip. There was a similar delay in differentiation at
the apical tip of Fgfr1-CKO cochleae relative to control (S1E Fig). Refer to S1D Fig for the loca-
tion of the apical tip.
FGFR1 but not FGF20 regulates Sox2 expression
Next, we examined Sox2 expression in Fgf20-KO and Fgfr1-CKO cochleae at E14.5 by RNA in
situ hybridization and immunofluorescence. In control cochleae, Sox2mRNA and protein
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Fig 1. The Fgf20-KO cochlear phenotype is less severe than the Fgfr1-CKO phenotype. (A, B) Whole mount cochlea from P0 Fgf20+/-, Fgf20-/-, and Foxg1Cre/+;
Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/- mice showing (A) inner and outer hair cells (IHC and OHC, phalloidin, green) separated by inner pillar cells (p75NTR, red) and (B)
supporting cells (Prox1 and Sox2, green/yellow). Magnifications show the basal, middle, and apical turns of the cochlea. Scale bar, 100 μm (magnifications), 1 mm
Sox2 and FGF20 interact in cochlea development
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008254 July 5, 2019 5 / 38
were highly expressed in the prosensory domain (Fig 2A, refer to Fig 2C). The expression of
Sox2 was not changed in Fgf20-KO cochleae compared to control; however, it was noticeably
decreased in Fgfr1-CKO cochleae (Fig 2A), in agreement with previous findings [19–21]. This
indicates that FGFR1 has an additional role, independent of FGF20, in regulating Sox2, which
is required for prosensory specification [12]. Similar to Sox2, CDKN1B expression in the pro-
sensory domain is also regulated by FGFR1, but not by FGF20 [18,19,21]. We confirmed these
results, finding that while CDKN1B expression was not changed in Fgf20-KO cochleae at
E14.5 relative to control, it was dramatically downregulated in Fgfr1-CKO cochleae (Fig 2B).
This is consistent with the role of Sox2 in regulating CDKN1B expression [12]. We hypothe-
size that a yet unidentified FGF ligand (in addition to or independent of FGF20) signaling via
FGFR1 regulates Sox2 expression (and therefore CDKN1B expression) during prosensory
specification, while FGF20 signaling via FGFR1 regulates differentiation (Fig 2D).
We also wanted to confirm that FGF20 signals to epithelial FGFR1 at around the initiation
of differentiation. To do so, we examined the expression of Etv4 (also known as Pea3) and
Etv5 (also known as Erm), two well-established downstream effectors of FGF signaling [23], by
in situ hybridization. The expression of these two genes are downregulated with FGF signaling
inhibition in E14 cochlear explants [17]. At E14.5, there were two domains of Etv4 and Etv5
expression in control cochleae: the prosensory domain and the outer sulcus (S2A Fig, brack-
ets). The outer sulcus is the region of the cochlear epithelium abneural to the prosensory
domain at E14.5. In Fgf20-KO cochleae, expression of both genes was not detected in the pro-
sensory domain. In Fgfr1-CKO cochleae, expression of both genes was similarly not detected
in the prosensory domain. Expression of Etv4 and Etv5 in the outer sulcus was not affected in
Fgf20-KO and Fgfr1-CKO cochleae (S2A Fig). These results confirm that FGF20 signals
through epithelial FGFR1 in the prosensory domain.
Previous studies have also reported a decrease in proliferation in Kölliker’s organ (neural to
the prosensory domain, S2B Fig) in Fgfr1-CKO cochleae [20]. We replicated this result by
examining EdU (5-ethynyl-2’-deoxyuridine) incorporation at E14.5. Fgfr1-CKO mice had a
complete lack of EdU-incorporating Kölliker’s organ cells, while Fgf20-KO mice did not show
a decrease in EdU incorporation (S2B Fig). This finding is also consistent with an additional
FGF ligand signaling via FGFR1, likely at an earlier stage. We do not know whether the prolif-
eration defect in Kölliker’s organ contributes to the reduction in HC and SC number in
Fgfr1-CKO mice.
Genetic rescue of the Fgf20-KO phenotype suggests that FGF20 is required
for differentiation
We have previously shown that recombinant FGF9, which is biochemically similar to FGF20
with similar receptor binding specificity [23,24], is able to rescue the loss of HCs and SCs in
Fgf20-KO explant cochleae [21]. Interestingly, while treatment with FGF9 at E13.5 and
E14.5 was able to rescue the Fgf20-KO phenotype, treatment at E15.5 was not. This temporal
rescue specificity suggests that FGF20 signaling is required for the initiation of HC and SC
differentiation.
(whole). (C-F) Quantification of (C) cochlear duct length, (D) total IHCs and IHCs per 100 μm of the cochlear duct, (E) total OHCs and OHCs per 100 μm, and (F)
total supporting cells (SCs) and SCs per 100 μm at P0. Fgf20+/- and Fgf20-/- cochleae results were analyzed by unpaired Student’s t test; Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;
Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- cochleae results were analyzed by one-way ANOVA. P values shown are from the t test and ANOVA. � indicates p< 0.05 from
Student’s t test or Tukey’s HSD (ANOVA post-hoc); n.s., not significant. Error bars, mean ± SD. n = (C) 4, 5, 7, 6, 7, 10; (D, E) 3, 4, 4, 3, 3, 6; (F) 4, 5, 3, 3, 4, 4. (G)
Schematic showing the positions of basal, middle, and apical turns along the cochlear duct. See also S1 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g001
Sox2 and FGF20 interact in cochlea development
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008254 July 5, 2019 6 / 38
Sox2 and FGF20 interact in cochlea development
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008254 July 5, 2019 7 / 38
To confirm the hypothesis that FGF20 is involved in differentiation and not specification
(Fig 2D), we sought to more accurately determine the temporal requirement of FGF20 signal-
ing. To achieve this, we developed an in vivo genetic rescue model of the Fgf20-KO phenotype
by ectopically expressing FGF9. We decided to use FGF9 again as we have already developed a
system for in vivo FGF9 expression. We combined Fgf20Cre with the Fgf20βgal [21], ROSArtTA
[25] and TRE-Fgf9-IRES-eGfp [26] alleles to generate Fgf9-rescue (Fgf20Cre/βgal;ROSArtTA/+;
TRE-Fgf9-IRES-eGfp) mice along with littermate controls: Fgf20-het (Fgf20Cre/+;ROSArtTA/+),
Fgf9-OA (Fgf20Cre/+;ROSArtTA/+;TRE-Fgf9-IRES-eGfp), and Fgf20-null (Fgf20Cre/βgal;
ROSArtTA/+). These mice express the reverse tetracycline transactivator (rtTA) in the Fgf20Cre
lineage, which contains the prosensory domain and Kölliker’s organ at E13.5 to E15.5 [18]. In
mice expressing TRE-Fgf9-IRES-eGfp, rtTA drives the expression of FGF9 upon doxycycline
(Dox) induction. The Fgf20βgal allele is another Fgf20-null allele, in which exon 1 of Fgf20 is
replaced by a sequence encoding β-galactosidase. We combined Fgf20Cre with Fgf20βgal to gen-
erate homozygous mutant mice while maintaining a constant dosage of Fgf20Cre in control and
knockout mice.
Initially, pregnant dams were fed a Dox diet from E13.5 to E15.5 and pups were harvested
at P0 to examine HC and SC development. As expected, Dox treatment itself did not appear to
affect HC or SC development in Fgf20-het and Fgf20-null cochleae, both of which showed the
expected phenotypes (Fig 3A and 3B). Ectopic expression of FGF9 during these stages also did
not affect HC or SC development in Fgf9-OA cochleae, showing that excess FGF20/FGF9 was
not sufficient to produce ectopic HCs and SCs. Importantly, ectopic expression of FGF9
resulted in a full rescue of the number and patterning of HCs and SCs in Fgf9-rescue pups.
The organ of Corti in these rescue pups had one row of IHCs, three rows of OHCs, and five
rows of SCs throughout the entire length of the cochlear duct, without any gaps (Fig 3A and
3B). This shows that FGF20/FGF9 signaling at E13.5-E15.5 is sufficient for HC and SC differ-
entiation. The quantified results from all of the rescue experiments are summarized in Fig 3C,
where the number of OHCs and SCs are represented as a percentage of that of Fgf20-het mice
treated with the same Dox regimen. All of the quantified data are presented in S3 Fig.
To more precisely determine the timing of rescue sufficiency, we fed pregnant dams Dox
for a period of 24 hours starting at E13.5, E14.5, or E15.5 (see S3 Fig for schematic of Dox regi-
mens). With E13.5 Dox, patterning and OHC number in the basal turn of the cochlea were
completely rescued in Fgf9-rescue mice (Fig 3A). However, OHC number in the middle and
particularly the apical turns were only partially rescued, resulting in regions with two rows of
OHCs instead of three. For instance, in the apical turn, OHC number was restored to 81% of
Fgf20-het mice, which is statistically significantly increased compared to Fgf20-null, but also
statistically significantly decreased compared to Fgf20-het, indicating partial rescue (Fig 3C).
With E14.5 Dox, patterning and OHC number in the middle and apical turns were completely
rescued. However, OHC number in the basal turn was not completely rescued, with regions of
one or two rows of OHCs, instead of three. With E15.5 Dox, patterning and OHC number was
not rescued in the basal and middle turns, as gaps still formed between islands of HCs (Fig
Fig 2. FGFR1 but not FGF20 regulates Sox2 expression. (A) Sections through the middle turn of E14.5 cochlear ducts from Fgf20+/-, Fgf20-/-, and
Foxg1Cre/+;Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/- mice. RNA in situ hybridization (top) and immunofluorescence for Sox2 (red, bottom), which is expressed in the
prosensory domain at this stage. Refer to schematic in (C). Samples are representative of n = (top) 3, 3, 3, 3; (bottom) 4, 4, 3, 3. (B) Immunofluorescence
for CDKN1B (green) in sections through the basal, middle, and apical turns of E14.5 Fgf20+/-, Fgf20-/-, and Foxg1Cre/+;Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/-
cochleae. Samples are representative of n = 5, 5, 3, 3. (C) Schematic of a cross section through the middle turn of the E14.5 cochlear duct, showing the
location of the prosensory domain (PD). Neural indicates the side of the duct towards the spiral ganglion cells; abneural indicates away. (D) A model of
genetic pathways during organ of Corti development. Ligand X/FGFR1 signaling regulates Sox2 expression during prosensory specification; FGF20/
FGFR1 signaling regulates differentiation. Ligand X may include FGF20, along with another functionally redundant ligand. DAPI, nuclei (blue). Scale bar,
100 μm. See also S2 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g002
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3A). However, OHC number in the apical turn was partially rescued, with two or three rows of
OHCs not separated by gaps towards the tip of the apex. In all of these experiments, the rescue
of SCs followed the same pattern as that of OHCs (Fig 3B).
These rescue results show that FGF20/FGF9 is sufficient for OHC and SC differentiation in
the basal turn of the cochlea at E13.5, in the middle and apical turns at E14.5-E15.5, and in the
tip of the apical turn at E15.5. Since the initiation of HC and SC differentiation occurs in the
base/mid-base of the cochlea at E13.5 and progresses apically over the next few days, these
results strongly imply that FGF20 functions during the initiation of differentiation, rather than
prosensory specification, consistent with our model (Fig 2D).
Fig 3. Genetic rescue of the Fgf20-KO phenotype suggests that FGF20 is required for differentiation. (A, B) Whole
mount cochlea from P0 Fgf20+/-;ROSArtTA (Fgf20-het), Fgf20+/-;ROSArtTA; TRE-Fgf9-IRES-eGfp (Fgf9-OA), Fgf20-/-;
ROSArtTA (Fgf20-null), and Fgf20-/-;ROSArtTA; TRE-Fgf9-IRES-eGfp (Fgf9-rescue) mice showing (A) inner and outer
hair cells (phalloidin, green) separated by inner pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2,
green/yellow). Images from basal, middle, and apical turns of the cochlea are shown. Fgf9-rescue cochleae from four
different doxycycline chow (Dox) regimens are shown (E13.5-E15.5, E13.5, E14.5, and E15.5). Fgf20-het, Fgf9-OA, and
Fgf20-null cochleae shown are from the E13.5-E15.5 Dox regimen. Scale bar, 100 μm. (C) Quantification of outer hair
cells (OHC) and supporting cells (SC) from P0 Fgf9-OA (Dox regimen: E13.5-E15.5), Fgf20-null (Dox regimen:
E13.5-E15.5), and Fgf9-rescue (all four Dox regimens) cochleae, presented as a percentage of the number of cells in
Fgf20-het cochleae from the same Dox regimen. � indicates p< 0.05 compared to Fgf20-null cochleae from the same
Dox regimen; ^ indicates p< 0.05 compared to Fgf20-het cochleae from the same Dox regimen; Tukey’s HSD (one-
way ANOVA post-hoc). See also S3 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g003
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Decrease in Sox2 expression results in similar phenotypes as disruptions to
FGFR1 signaling
Our results and previous findings suggest that FGFR1 regulates prosensory specification via
Sox2 [19]. Mice with an inner ear-specific Sox2 hypomorphic mutation (Sox2Ysb/Ysb, see
below) have defects in prosensory specification, accounting for a small loss of HCs and SCs,
whereas mice with inner-ear specific Sox2 null mutations have a complete lack of prosensory
specification and a complete absence of sensory epithelium [12]. To examine how much the
reduction in Sox2 expression in Fgfr1-CKO cochlea contributes to the phenotype at P0, we
combined the Sox2- (Sox2 constitutive null) and Sox2Ysb alleles to closely examine the effects of
reduction in Sox2 expression on organ of Corti development, on a similar genetic background
as our Fgf20-KO and Fgfr1-CKO mice. We hypothesized that if Fgfr1 acts upstream of Sox2,
then reducing Sox2 expression should at least partially recapitulate the Fgfr1-CKO cochlea
phenotype. The Sox2Ysb allele is a regulatory mutant in which transgene insertion in chromo-
some 3 disrupts some otic enhancers, resulting in hypomorphic Sox2 expression in the inner
ear [11,12].
We generated a Sox2 allelic series of mice with the following genotypes, in order of highest
to lowest levels of Sox2 expression: Sox2+/+ (wildtype), Sox2Ysb/+, Sox2Ysb/Ysb, and Sox2Ysb/-. In
this allelic series, decrease in Sox2 expression had a dose-dependent effect on cochlea length at
P0 (Fig 4A–4C). Sox2Ysb/+ cochleae had a 6% reduction in length compared to wildtype
(although not statistically significant), Sox2Ysb/Ysb cochleae had a 24% reduction, and Sox2Ysb/-
had a 46% reduction. Sox2Ysb/+ organ of Corti developed relatively normally, with three rows
of OHCs and one row of IHCs (Fig 4A). Interestingly, there were occasional ectopic IHCs neu-
ral (inner) to the normal row of IHCs, especially in the middle and apical turns of the Sox2Ysb/
+ cochlea (Fig 4A, arrowheads). However, there was no significant increase in IHC number
(total or normalized to length) compared to wildtype cochleae (Fig 4D). The Sox2Ysb/Ysb
cochlea appeared much more abnormal, with gaps in the sensory epithelium that lacked HCs
and SCs in the basal turn (Fig 4A and 4B), similar to what was observed previously [12]. More-
over, at the base, in the sensory islands between the gaps, there were often four rows of OHCs
and six rows of SCs. In the middle and apical turns, there were the normal three rows of OHCs
and five rows of SCs. There were also numerous ectopic IHCs throughout the middle and api-
cal turns, sometimes forming an entire second row of cells (Fig 4A), resulting in increased
number of IHCs in the middle turn compared to wildtype (S4A Fig). However, the total and
length-normalized number of IHCs in Sox2Ysb/Ysb cochleae did not significantly differ from
that of wildtype cochleae (Fig 4D). In terms of OHCs, Sox2Ysb/Ysb cochleae exhibited a 40%
decrease in total number compared to wildtype cochleae (Fig 4E). This decrease was not quite
as severe when normalized to cochlear length (21% decrease). Strikingly, Sox2Ysb/- cochleae
lacked almost all HCs and SCs, except in the apical turn (Fig 4A and 4B). The decrease in
OHC number (93%) in Sox2Ysb/- cochleae compared to wildtype was more severe than the
decrease in IHC number (75%). Notably, IHC number was significantly decreased in the basal
and middle turns, but not in the apical turn (S4A Fig). OHC number was significantly
decreased throughout all three turns (S4B Fig). In all of these genotypes, the number of SCs
followed the pattern of loss of OHCs (Fig 4F and S4C Fig). Interestingly, while Sox2Ysb/-
cochleae almost completely lacked HCs and SCs in the basal and middle turns, in 7 of 11 Sox2-
Ysb/- cochleae examined, one or two small islands of HCs or SCs were found at the basal tip
(S4D Fig).
Overall, these results showed that the basal end of the cochlea is more sensitive to the loss of
Sox2 expression than the apical end. Furthermore, while both IHCs and OHCs were affected,
OHCs were more sensitive to decrease in Sox2 expression than IHCs. Importantly, both of
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these features were found in Fgfr1-CKO cochleae, where the decrease in IHCs was only found in
the basal and middle turns and there were almost no OHCs along the entire cochlear duct (S1A
and S1B Fig). Therefore, we conclude that decrease in Sox2 expression, leading to defects in pro-
sensory specification, could account for the Fgfr1-CKO phenotype. Furthermore, the decrease
in Sox2 expression could also account for the difference in severity between the Fgf20-KO and
Fgfr1-CKO phenotypes, since Fgf20-KO cochleae, which had normal Sox2 expression, did not
have a decrease in the number of IHCs, unlike Fgfr1-CKO and Sox2Ysb/- cochleae.
Decrease in levels of Sox2 expression delays prosensory specification
We sought to determine why a decrease in Sox2 expression more severely affected the basal
end of the cochlear duct. Initially, we examined Sox2 expression at E14.5. As expected, Sox2
Fig 4. Decrease in Sox2 expression results in similar phenotypes as disruptions to FGFR1 signaling. (A, B) Whole
mount cochlea from P0 mice from the Sox2 allelic series (in order of highest to lowest levels of Sox2 expression: Sox2+/
+, Sox2Ysb/+, Sox2Ysb/Ysb, and Sox2Ysb/-) showing (A) inner and outer hair cells (phalloidin, green) separated by inner
pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2, green/yellow). Magnifications show the basal,
middle, and apical turns of the cochlea. Arrowheads indicate ectopic inner hair cells. Scale bar, 100 μm
(magnifications), 1 mm (whole). (C-F) Quantification of (C) cochlear duct length, (D) total inner hair cells (IHCs) and
IHCs per 100 μm of the cochlear duct, (E) total outer hair cells (OHCs) and OHCs per 100 μm, and (F) total
supporting cells (SCs) and SCs per 100 μm at P0. P values shown are from one-way ANOVA. � indicates p< 0.05 from
Tukey’s HSD (ANOVA post-hoc). Error bars, mean ± SD. n = (C) 7, 7, 8, 8; (D, E) 4, 4, 4, 4; (F) 4, 5, 3, 3. See also S4
Fig.
https://doi.org/10.1371/journal.pgen.1008254.g004
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expression was almost completely absent in Sox2Ysb/- cochleae (S5A Fig). This decrease in
expression was not more severe at the basal turn of the cochlear duct, relative to the middle
and apical turns, suggesting that the more severe basal phenotype in Sox2Ysb/- cochleae cannot
be explained by differential Sox2 expression. Similarly, CDKN1B expression was downregu-
lated in the prosensory domain of Sox2Ysb/- cochleae, consistent with previous studies [12].
Interestingly, the decrease in expression was also not more severe at the basal turn relative to
the middle and apical turns (S5B Fig). Using CDKN1B as a marker of prosensory specification,
this suggests that the more severe basal phenotype also cannot be explained by differential reg-
ulation of prosensory specification along the length of the cochlea.
As described in the introduction, the wave of cell cycle exit (marking the completion of pro-
sensory specification) and the wave of differentiation travel in opposite directions along the
cochlear duct during development, resulting in the basal end of the cochlear duct differentiat-
ing immediately after specification. The apical end, meanwhile, exhibits a delay in differentia-
tion, resulting in a longer temporal buffer between specification and differentiation. In this
developmental pathway, specification must be completed prior to the initiation of differentia-
tion. We reasoned, therefore, that disruptions to the timing of prosensory specification will
preferentially interfere with basal sensory epithelia development, potentially accounting for
the more severe basal phenotype in Sox2 hypomorphs. Notably, Sox2 expression in the prosen-
sory domain has recently been shown to follow an apical-to-basal pattern, suggesting that Sox2
may play a role in the apical-to-basal progression of cell cycle exit and the completion of pro-
sensory specification [27].
To test this hypothesis, we examined cell cycle exit in the prosensory domain via Ki67 ex-
pression, as a marker of the status of prosensory specification. Ki67 is expressed by cycling cells,
but not cells in the G0 phase of the cell cycle [28]. In the developing cochlea at around E12.5 to
E15.5, cells of the prosensory domain, sometimes referred to as the zone of non-proliferation,
have turned off or are beginning to turn off Ki67 expression as they exit the cell cycle [3]. At
E14.5 in Sox2Ysb/+ cochleae, the prosensory domain along most of the cochlear duct (serial sec-
tions 2–6) has turned off Ki67 expression, except at the very base (serial section 1; Fig 5A, brack-
ets). See graphical summary below Fig 5A; also see S5C Fig for serial “mid-modiolar” sections
through the cochlea. This indicates that the wave of cell cycle exit, which starts at the apex, has
reached the very base of the cochlear duct. However, in Sox2Ysb/- cochleae, only the prosensory
domain at the apical turn of the cochlear duct (serial section 6) has turned off Ki67, not at the
mid-basal or basal turns (serial sections 1–3); the middle turns (serial sections 4 and 5), mean-
while, were just starting to turn off Ki67 (Fig 5A, brackets). In all, in the 5 Sox2Ysb/+ cochleae
examined, the most basal section that has not yet turned off Ki67 are 1, 1, 1, 1, and 2; in the 6
Sox2Ysb/- cochleae examined, they are 4, 4, 4, 5, 5, and 5 (p = 0.008, Mann-Whitney U test).
This indicates that in Sox2Ysb/- cochleae, cell cycle exit is delayed relative to Sox2Ysb/+ cochleae,
suggesting a delay in the completion of prosensory specification. In addition, the nuclei of pro-
sensory domain cells shift away from the luminal surface of the cochlear epithelium upon speci-
fication [29]. This basal shift of nuclei localization within the cell leaves a blank space between
DAPI-stained nuclei and the luminal surface of the cochlear duct, which can be visualized in all
six serial sections in Sox2Ysb/+ cochleae at E14.5 (Fig 5A, asterisks). However, in Sox2Ysb/-
cochleae, cells of the prosensory domain mostly did not exhibit this nuclei shift at E14.5.
At E15.5, the prosensory domain along the entire length of the cochlear duct has turned off
Ki67 expression in both Sox2Ysb/+ and Sox2Ysb/- cochleae, in all samples examined (Fig 5A,
brackets). This suggests that cell cycle exit and prosensory specification in Sox2Ysb/- cochleae
has caught up by this stage. Prosensory nuclei localization has also begun to catch up at E15.5
in Sox2Ysb/- cochleae (Fig 5A, asterisks). Overall, these results suggest that prosensory specifica-
tion is delayed in Sox2Ysb/- cochleae, but not permanently disrupted.
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Fig 5. Decrease in levels of Sox2 expression delays prosensory specification. (A) Serial sections (1–6) through the duct of E14.5
and E15.5 Sox2Ysb/+ and Sox2Ysb/- cochleae. Immunofluorescence for Ki67 (red) and DAPI (nuclei, cyan). Cochlear epithelium is
outlined. Bracket indicates prosensory domain. � indicates shift of prosensory nuclei away from the luminal surface of the
epithelium. N, neural side. Scale bar, 100 μm. Samples are representative of n = (E14.5) 5, 6; (E15.5) 3, 3. Whole mount cochlear
duct schematics show relative positions of the serial sections and progression of cell cycle exit (green arrow). (B) A model of organ
of Corti development showing embryonic staging (x-axis) and location along the cochlear duct (basal, middle, and apical turns, y-
axis). Development occurs in two stages: unspecified progenitors (tan shading) undergo specification and cell cycle exit to become
prosensory cells (green shading), which then differentiate into hair cells and supporting cells (HCs & SCs; red shading). In
wildtype cochleae, cell cycle exit (indicating completion of specification) begins at the apex of the cochlea and proceeds basally.
Afterwards, differentiation initiates at the mid-base of the cochlea and proceeds basally and apically. Temporal buffer (green
shading) refers to the time between cell cycle exit and initiation of differentiation. In Sox2 hypomorph cochleae, specification and
cell cycle exit are delayed, resulting in failure to complete specification before initiation of differentiation towards the basal end of
the cochlea (crosshatch pattern). See also S5 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g005
Sox2 and FGF20 interact in cochlea development
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008254 July 5, 2019 13 / 38
Prosensory specification must occur prior to differentiation to generate HCs and SCs.
Therefore, the period of time in between cell cycle exit and the initiation of differentiation rep-
resents a temporal buffer (Fig 5B, green shading) preventing differentiation from initiating
prior to specification. As differentiation begins in the basal/mid-basal cochlear turns shortly
after specification, the delay in specification in Sox2Ysb/- cochleae leads to progenitors not hav-
ing been specified in time for differentiation at the basal end of the cochlear duct (Fig 5B,
crosshatch pattern). We propose that this at least partially explains why the basal end of the
cochlea is more sensitive to decreases in the level of Sox2 expression. Moreover, since differen-
tiation begins in the mid-base and spreads to the rest of the base, progenitors at the basal tip in
Sox2Ysb/- cochleae may still have time to undergo specification prior to differentiation. This
may explain why small islands of HCs and SCs are sometimes seen in the basal tip of Sox2Ysb/-
cochleae (S4D Fig).
Notably, while we detected a difference in Ki67 expression between Sox2Ysb/+ and Sox2Ysb/-
cochleae at E14.5 (Fig 5A), we did not detect a difference in EdU incorporation after 1 hour of
EdU injection. In the basal turn of Sox2Ysb/- cochleae at E14.5, cells of the presumptive prosen-
sory domain still expressed Ki67, but did not incorporate EdU (S6A Fig, brackets). This indi-
cates that while these presumptive prosensory cells have not exited the cell cycle, they are no
longer actively undergoing DNA synthesis. We predict that these cells are either cycling slowly
or are transiently “stuck” at a particular stage of the cell cycle.
Sox2 is upstream of Fgf20
While the delay in prosensory specification can explain the preferential loss of sensory epithe-
lium from the basal end of Sox2 hypomorph cochleae, it does not readily explain the preferen-
tial loss of OHCs, relative to IHCs. Since this preference for OHC loss is reminiscent of the
Fgf20/Fgfr1 deletion phenotypes, we investigated the possibility that Sox2may be upstream of
FGF20-FGFR1 signaling. Interestingly, both Etv4 and Etv5 were dramatically downregulated
in the prosensory domain of Sox2Ysb/- cochleae compared to control (Fig 6A). This shows that
FGF20-FGFR1 signaling was disrupted in the Sox2 hypomorph cochleae. Examination of Fgfr1
and Fgf20 expression by in situ hybridization revealed that while Fgfr1 expression did not
appear to be affected in Sox2Ysb/- cochleae at E14.5, Fgf20 expression was absent (Fig 6B). This
suggests that while Fgfr1 functions upstream of Sox2 (Fig 2A), Fgf20 is downstream of Sox2.
This model predicts that Fgf20 expression would be downregulated in Fgfr1-CKO cochleae,
which was confirmed by in situ hybridization (Fig 6C).
The above results indicate that the loss of Fgf20 could partially account for the Sox2Ysb/- phe-
notype. Therefore, to determine whether loss of Fgf20 also causes delayed prosensory specifica-
tion, we examined Ki67 expression in Fgf20-KO cochleae. At E14.5, there was no detectable
delay in cell cycle exit in Fgf20-KO cochleae, as loss of Ki67 expression reached the base (serial
section 1) in all 6 control and all 6 Fgf20-KO cochleae examined (S6B Fig, brackets). There was
also no detectable delay in prosensory basal nuclei shift in Fgf20-KO cochleae (S6B Fig, aster-
isks). These results were expected as the Fgf20-KO phenotype is not more severe at the basal
end of the cochlear duct. This is also consistent with Fgf20 being required during differentia-
tion rather than prosensory specification (Fig 2D). However, these results do not answer
whether and how the loss of Fgf20 contributes to the Sox2 hypomorph phenotype.
Since Fgfr1 is upstream of Sox2, we next asked whether Fgfr1 deletion also results in a delay
in prosensory cell cycle exit via decrease in Sox2 expression. Interestingly, similar to the
Fgf20-KO, there was no detectable delay in cell cycle exit or basal nuclei shift in Fgfr1-CKO
cochleae compared to control at E14.5 (S6B Fig, brackets, asterisks). We hypothesized that this
lack of a detectable difference may be due to the relatively small reduction in Sox2 expression
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in Fgfr1-CKO cochleae compared to Sox2Ysb/- cochleae. To examine cell cycle exit more closely
for subtle changes, we used Sox2 as a marker of prosensory cells and quantified the number of
Sox2-expressing cells that also expressed Ki67 in serial sections through the cochlear duct.
Because at E14.5 Sox2 also labels the Kölliker’s organ, which is neural (inner) to the prosensory
Fig 6. Sox2 is upstream of Fgf20. (A-C) Sections through the middle turn of E14.5 cochleae.(A) RNA in situ hybridization for Etv4 and
Etv5 in Sox2Ysb/+ and Sox2Ysb/- cochleae. The two brackets indicate Etv4/5 expression in the outer sulcus (OS, left) and prosensory
domain (PD, right). Refer to schematic at the bottom of the figure. Samples are representative of n = (Etv4) 4, 4; (Etv5) 4, 4. (B) RNA in
situ hybridization for Fgfr1 and Fgf20 in Sox2Ysb/+ and Sox2Ysb/- cochleae. Bracket indicates Fgfr1/Fgf20 expression in the prosensory
domain. Samples are representative of n = (Fgfr1) 3, 3; (Fgf20) 3, 3. (C) RNA in situ hybridization for Fgf20 in Foxg1Cre/+;Fgfr1flox/+ and
Foxg1Cre/+;Fgfr1flox/- cochleae. Bracket indicates Fgf20 expression in the prosensory domain. Samples are representative of n = 3, 3. (D)
Immunofluorescence for Sox2 (green) and Ki67 (red) in sections through the mid-basal turn (serial section 3, refer to schematic below)
of E14.5 Fgf20+/-, Fgf20-/-, Foxg1Cre/+;Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- cochlear duct floor. Bracket indicates prosensory domain (PD).
Arrowheads indicate Ki67+/Sox2+ cells at the abneural border of the prosensory domain.(E) Quantification of total number of Ki67
+/Sox2+ cells at the abneural border of the prosensory domain in serial sections 2–6 of E14.5 Fgf20+/-, Fgf20-/-, and Foxg1Cre/+;Fgfr1flox/+,
Foxg1Cre/+;Fgfr1flox/- cochleae. P values shown are from unpaired Student’s t test. � indicates p< 0.05; n.s., not significant. Error bars,
mean ± SD. n = 4, 4, 5, 5. Whole mount cochlear duct schematic shows relative positions of the serial sections. OS, outer sulcus; PD,
prosensory domain; KO, Kölliker’s organ. Scale bar, 100 μm (A-C), 50 μm (D). See also S6 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g006
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domain, we quantified cells at the abneural (outer) border of the prosensory domain. In E14.5
Fgf20-KO cochleae, a few Ki67+/Sox2+ cells could be found at the abneural border, mostly
towards the basal end of the cochlear duct, similar to control cochleae (Fig 6D and 6E). How-
ever, there were significantly more Ki67+/Sox2+ cells at the abneural border in Fgfr1-CKO
cochleae compared to control (Fig 6D and 6E, arrowheads). This shows that, as expected, dele-
tion of Fgfr1, but not Fgf20, does lead to a quantifiable defect in prosensory cell cycle exit.
We also asked whether a decrease in Sox2 expression can account for the absence of prolifera-
tion in Kölliker’s organ in Fgfr1-CKO cochleae. Interestingly, EdU-incorporation was decreased
in Kölliker’s organ in Sox2Ysb/- cochleae at E14.5, especially in the region adjacent to the prosen-
sory domain (S6C Fig, bracket). However, EdU-incorporation was not completely absent from
Kölliker’s organ, unlike in Fgfr1-CKO cochleae. This suggests that loss of Sox2 in combination
with other factors contributes to the Kölliker’s organ phenotype in Fgfr1-CKO cochleae.
Sox2 and Fgf20 interact during cochlea development
To explore how the loss of Fgf20 contributes to the Sox2 hypomorph phenotype, we combined
the Fgf20- and Sox2Ysb alleles to generate Fgf20 and Sox2 compound mutants. We also hypothe-
sized that reducing Sox2 expression in Fgf20-KO mice would recapitulate (or phenocopy) the
more severe Fgfr1-CKO phenotype. We interbred F1 mice from the same parents to generate
nine different F2 genotypes encompassing all possible combinations of the Fgf20- and Sox2Ysb
alleles: Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+, Fgf20+/-;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2-
Ysb/Ysb, Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb (Figs 7
and 8). At P0, an overview of HCs and SCs showed that the Fgf20+/-;Sox2Ysb/+ phenotype
mostly resembled that of Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+, and Fgf20+/-;Sox2+/+ cochleae,
except for the prevalence of ectopic IHCs (Fig 7A, arrowheads). The Fgf20+/-;Sox2Ysb/Ysb phe-
notype mostly resembled that of Fgf20+/+;Sox2Ysb/Ysb cochleae, but with more gaps in the basal
cochlear turn and two rows of IHCs throughout the length of the cochlear duct, except where
there were gaps. The Fgf20-/-;Sox2Ysb/+ phenotype mostly resembled that of Fgf20-/-;Sox2+/+
cochleae, but with smaller sensory islands in between gaps. The Fgf20-/-;Sox2Ysb/Ysb phenotype
appeared by far the most severe, with almost a complete absence of IHCs, OHCs, and SCs
from the basal turn, and tiny sensory islands in the middle turn; however, the apical turn
appeared similar to that of Fgf20-/-;Sox2Ysb/+ and Fgf20-/-;Sox2+/+ cochleae (Fig 7A and 7B).
Quantification of the phenotypes are presented in Fig 8B–8E and S7B–S7D Fig. We ana-
lyzed the quantified P0 phenotype via two-way ANOVA with the two factors being gene dos-
age of Fgf20 (levels: Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (levels: Sox2+/+, Sox2Ysb/+, Sox2Ysb/
Ysb). Results from the two-way ANOVA and post-hoc Tukey’s HSD are presented in Fig 8A
and 8F and S7A and S8 Figs. Cochlear length and the total number of IHCs, OHCs, and SCs
were all significantly affected by both the Fgf20 dosage and the Sox2 dosage, as well as an inter-
action between the two factors (Fig 8A–8E). The statistically significant interaction between
Fgf20 and Sox2 dosages suggests that Fgf20 and Sox2 have a genetic interaction in regulating
cochlear length as well as the number of IHCs, OHCs, and SCs (Fig 8A). Notably, Fgf20+/-;
Sox2Ysb/Ysb cochleae had significantly fewer OHCs and SCs than Fgf20+/+;Sox2Ysb/Ysb cochleae,
and Fgf20-/-;Sox2Ysb/+ cochleae had significantly fewer OHCs than Fgf20-/-;Sox2+/+ cochleae
(Fig 8F). Importantly, Fgf20-/-;Sox2Ysb/Ysb cochleae had decreased total and length-normalized
number of IHCs, which was not observed in any of the other genotypes, strongly supporting a
genetic interaction between Fgf20 and Sox2 (Fgf20+/+;Sox2Ysb/Ysb cochleae did have a slight
decrease in the total number of IHCs, but not in the length-normalized number of IHCs).
Interestingly, while the total number of IHCs was decreased in Fgf20-/-;Sox2Ysb/Ysb cochleae
relative to all other genotypes, this decrease was only found in the basal and middle turns, but
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not the apical turn (S7B and S8 Figs). No such basal/middle/apical turn discrepancies existed
in the number of OHCs or SCs (S7C, S7D and S8 Figs). This is reminiscent of the Fgfr1-CKO
and Sox2Ysb/- phenotypes.
To ensure that the Fgf20- and Sox2Ysb interaction is not purely an artifact of the Sox2Ysb
allele, we generated Fgf20+/+;Sox2+/+ (wildtype), Fgf20+/-;Sox2+/+ (Fgf20-het), Fgf20+/+;Sox2+/-
(Sox2-het), and Fgf20+/-;Sox2+/- (double het) mice to look for an interaction between the Fgf20-
and Sox2- alleles (S9A Fig). At P0, cochlear length did not significantly differ among the four
genotypes (S9B Fig). HC quantification showed that neither Fgf20 nor Sox2 exhibited haploin-
sufficiency for total or length-normalized number of IHCs or OHCs (S9C and S9D Fig). How-
ever, in Fgf20-het and much more so in Sox2-het cochleae, occasional ectopic IHCs can be
found in the middle and apical turns of the cochlear duct (S9A Fig, arrowheads). Interestingly,
in double het cochleae, many more ectopic IHCs were found, even in the basal turn. These
ectopic IHCs led to an increase in the total and length-normalized number of IHCs in double
het cochleae, compared to wildtype (S9C Fig). Notably, a significant increase in IHCs was only
found in the basal turn, not the middle or apical turns (S9E Fig). In the basal turn, IHC num-
ber was significantly increased in double het cochleae compared to wildtype, Fgf20-het, and
Sox2-het cochleae. Double het cochleae also had a significant decrease in total and length-nor-
malized number of OHCs compared to wildtype (S9D Fig). Again, a significant decrease in
OHCs was only found in the basal turn, not the middle or apical turns (S9F Fig). These results
confirm a genetic interaction between Fgf20 and Sox2.
Loss of Fgf20 does not further delay prosensory specification in Sox2
hypomorph cochleae
We propose that the Fgf20-/-;Sox2Ysb/Ysb phenotype lies in between that of Fgfr1-CKO and
Sox2Ysb/- in terms of severity of reductions in cochlear length and in the number of HCs and
SCs. We further hypothesize that these three phenotypes form a continuum with the
Fgf20-KO phenotype (Fig 9A). Along this continuum, all four genotypes lack FGF20 signaling,
but vary in the level of Sox2 expression and phenotype severity in the basal end of the cochlear
duct and the outer compartment (outer rows of OHCs and SCs). From this, and from the
Fgf20- and Sox2Ysb series of alleles, we conclude that the basal end of the cochlear duct and the
outer compartment are more sensitive to the loss of Fgf20 and Sox2, relative to the apical end
and inner compartment, respectively.
To determine the mechanism underlying the Sox2 and Fgf20 interaction, we asked whether
the loss of Fgf20 further reduces Sox2 expression on a Sox2 hypomorphic background. In other
words, we asked whether Fgf20 has a role in regulating Sox2 expression on a sensitized back-
ground. Examination of prosensory domain Sox2 expression at E14.5 revealed, as expected,
that Fgf20-/-;Sox2Ysb/+ cochleae did not have a decrease in Sox2 expression compared to
Fgf20+/-;Sox2Ysb/+ (S10A Fig). Fgf20-/-;Sox2Ysb/Ysb cochleae also did not have a further decrease
in Sox2 expression compared to Fgf20+/-;Sox2Ysb/Ysb cochleae. Moreover, despite the loss of
sensory epithelium in most of the basal turn, Sox2 expression was not further decreased in the
basal turn at E14.5 relative to the rest of the Fgf20-/-;Sox2Ysb/Ysb cochlea (S10A Fig). A similar
pattern of expression was observed for CDKN1B across the different genotypes (S10B Fig).
Fig 7. Sox2 and Fgf20 interact during cochlea development. (A, B) Whole mount cochlea from P0 Fgf20+/-;Sox2Ysb/+,
Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb mice showing (A) inner and outer hair cells (phalloidin,
green) separated by inner pillar cells (p75NTR, red) and (B) supporting cells (Prox1 and Sox2, green/yellow).
Magnifications show the basal, middle, and apical turns of the cochlea. Arrowheads indicate ectopic inner hair cells.
Scale bar, 100 μm (magnifications), 1 mm (whole).
https://doi.org/10.1371/journal.pgen.1008254.g007
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Fig 8. Sox2 and Fgf20 interact during cochlea development—quantitative analysis. (A) P values from two-way ANOVA analyzing the
quantification results in (B-E). The two factors analyzed are Fgf20 (Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2 (Sox2+/+, Sox2Ysb/+, Sox2Ysb/Ysb) gene
dosage. A p value< 0.05 (yellow highlight) for Fgf20 or Sox2 indicates that the particular factor (independent variable) has a statistically
significant effect on the measurement (dependent variable). Whereas a p value< 0.05 (orange highlight) for Interaction indicates a statistically
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Loss of Fgf20 did not contribute to a further decrease in CDKN1B expression on a Sox2Ysb/Ysb
background, nor was there a basal-apical difference in CDKN1B expression in Fgf20-/-;Sox2Ysb/
Ysb cochleae at E14.5. These results are consistent with our hypothesis that Fgf20 does not regu-
late Sox2 expression or prosensory specification.
Next, we asked whether Sox2 and Fgf20 interact to delay prosensory specification. We
showed that Fgf20-KO cochleae do not exhibit a delay in prosensory specification (Fig 6D and
6E). However, this does not rule out the possibility that the loss of Fgf20may contribute to a
delay on a Sox2 hypomorphic background. We examined Ki67 expression at E14.5 and found
that in Fgf20+/-;Sox2Ysb/+ cochleae, prosensory domain cell cycle exit has reached the end of the
base (serial section 1; S10D Fig, brackets). Similarly, cell cycle exit in Fgf20-/-;Sox2Ysb/+ cochleae
also reached the end of the base. As expected, Fgf20+/-;Sox2Ysb/Ysb cochleae exhibited a slight
delay in prosensory specification; cell cycle exit has reached the base (serial section 2), but has
not yet reached the end of the base (serial section 1). Importantly, Fgf20-/-;Sox2Ysb/Ysb cochleae
did not show a further delay relative to Fgf20+/-;Sox2Ysb/Ysb. There was also no detectable delay
in nuclei shift in Fgf20-/-;Sox2Ysb/+ or Fgf20-/-;Sox2Ysb/Ysb cochleae (S10D Fig, asterisks). We
then quantified the number of Sox2-expressing prosensory cells that still express Ki67 in serial
sections through the cochlear duct at E14.5. As expected, both Fgf20+/-;Sox2Ysb/Ysb and Fgf20-/-;
Sox2Ysb/Ysb cochleae had significantly more Ki67+/Sox2+ cells than Fgf20+/-;Sox2Ysb/+ cochleae,
confirming that decrease in Sox2 expression delays specification (Fig 9B and 9C, arrowheads).
Importantly, loss of Fgf20 alone had no detectable effect on the number of Ki67+/Sox2+ cells:
Fgf20-/-;Sox2Ysb/+ and Fgf20-/-;Sox2Ysb/Ysb cochleae did not have significantly more Ki67+/Sox2
+ cells than Fgf20+/-;Sox2Ysb/+ and Fgf20+/-;Sox2Ysb/Ysb cochleae, respectively (Fig 9B and 9C).
These results suggest that the loss of Fgf20 does not contribute to delayed specification, even
on a Sox2 hypomorphic background. They also show that the severity of the Fgf20-/-;Sox2Ysb/Ysb
basal phenotype cannot be completely attributed to delayed specification.
Lastly, we examined proliferation in the Kölliker’s organ of Fgf20- and Sox2Ysb E14.5
cochleae. Interestingly, there was a noticeable decrease in the number of EdU-incorporating
cells in Kölliker’s organ in Fgf20-/-;Sox2Ysb/Ysb cochleae, compared to Fgf20+/-;Sox2Ysb/+,
Fgf20-/-;Sox2Ysb/+, and Fgf20+/-;Sox2Ysb/Ysb cochleae (S10C Fig). This phenotype is similar to
that of Sox2Ysb/- cochleae and is less severe than that of Fgfr1-CKO cochleae. This suggests that
Fgf20 and Sox2 interact to regulate proliferation in Kölliker’s organ, although other factors
downstream of Fgfr1 also contribute. One such factor could be Fgf10, which has been shown to
be downregulated in the Kölliker’s organ in Fgfr1-mutant mice [19].
Fgf20-KO organ of Corti exhibits premature differentiation
We showed that based on the timing of FGF9 rescue, Fgf20 likely plays a role during the initia-
tion of differentiation. Previous studies showed that deletion of both transcription factors
Hey1 and Hey2 results in premature differentiation in the organ of Corti [30]. Furthermore, it
has been suggested that FGF signaling, in particular FGF20, regulatesHey1 andHey2 expres-
sion during this process [8,30]. To test whether Fgf20 is upstream ofHey1 andHey2, we looked
significant interaction between the effects of the two factors on the measurement. (B-E) Quantification of (B) cochlear duct length, (C) total inner
hair cells (IHCs) and IHCs per 100 μm of the cochlear duct, (D) total outer hair cells (OHCs) and OHCs per 100 μm, and (E) total supporting
cells (SCs) and SCs per 100 μm at P0 in Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+, Fgf20+/-;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2Ysb/Ysb, Fgf20+/-;
Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb cochleae. Error bars, mean ± SD. n = (B) 5, 6, 5, 6, 6, 6, 4, 10, 10; (C, D) 5, 5,
5, 4, 4, 4, 4, 5, 6; (E) 4, 5, 3, 3, 3, 3, 3, 5, 5. (F) Results from post-hoc Tukey’s HSD analyzing the quantification results in (B-E). Letters (L, I, J, O, P,
S, T; representing each measurement in panels B-E) indicate a statistically significant decrease (p< 0.05) when comparing the row genotype
against the column genotype. L, cochlear length; I, total IHCs; J, IHCs/100 μm; O, total OHCs; P, OHCs/100 μm; S, total SCs; T, SCs/100 μm. See
also S7 and S8 Figs.
https://doi.org/10.1371/journal.pgen.1008254.g008
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at the expression of the two transcription factors via in situ hybridization. In Fgf20-KO
cochleae at E14.5,Hey1 expression is downregulated whileHey2 is almost completely absent
compared to control (Fig 10A). To test whether FGF20 loss leads to premature differentiation,
we examined myosin VI (Myo6) expression, a marker of differentiated HCs [30]. At E14.5, the
cochleae of 3 of 12 control embryos examined contained Myo6-expressing HCs, while the
Fig 9. Loss of Fgf20 does not further delay prosensory specification in Sox2 hypomorph cochleae. (A) The Fgf20-/-,
Foxg1Cre/+;Fgfr1flox/-, Fgf20-/-;Sox2Ysb/Ysb, and Sox2Ysb/- cochleae phenotypes lie along a continuum, preferentially affecting
outer and basal cochlear sensory epithelium, likely attributable to varying Sox2 levels on an Fgf20-null background. (B)
Immunofluorescence for Sox2 (green) and Ki67 (red) in sections through the mid-basal turn (serial section 3, refer to
schematic to the right) of E14.5 Fgf20+/-;Sox2Ysb/+, Fgf20-/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb, and Fgf20-/-;Sox2Ysb/Ysb cochlear duct
floor. Bracket indicates prosensory domain (PD). Arrowheads indicate Ki67+/Sox2+ cells at the abneural border of the
prosensory domain. Scale bar, 50 μm. (C) Quantification of total number of Ki67+/Sox2+ cells at the abneural border of the
prosensory domain in serial sections 2–6 of E14.5 Fgf20+/-;Sox2Ysb/+, Fgf20-/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb, and Fgf20-/-;
Sox2Ysb/Ysb cochleae. P value shown is from one-way ANOVA. � indicates p< 0.05 from Tukey’s HSD (ANOVA post-hoc).
Error bars, mean ± SD. n = 4, 4, 4, 4. Whole mount cochlear duct schematic shows relative positions of the serial sections.
Note: unlike in Fig 7, the placement of images from Fgf20-/-;Sox2Ysb/+ and Fgf20+/-;Sox2Ysb/Ysb cochleae have been switched to
facilitate comparison. See also S10 Fig.
https://doi.org/10.1371/journal.pgen.1008254.g009
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cochleae of 18 of 19 littermate Fgf20-KO embryos contained Myo6-expressing HCs (p<
0.001, Fisher’s exact test; Fig 10B). If present, the Myo6-expressing HCs at this stage were
always found in the basal and mid-basal turns of the cochlea. These results show that there is
premature onset of differentiation in Fgf20-KO cochleae, which begins in the basal/mid-basal
turns. This result is surprising given our previous finding of delayed differentiation in the api-
cal end of Fgf20-KO cochleae at later stages, which we confirm here (S1E Fig). These findings
suggest that while initiation of differentiation occurs earlier in Fgf20-KO cochleae, apical pro-
gression of differentiation may be slower.
Next, we asked whether ectopic activation of FGF signaling via overexpression of FGF9 will
delay the onset of differentiation. We generated Fgf20-het (Fgf20Cre/+;ROSArtTA/+), Fgf20-null
(Fgf20Cre/βgal;ROSArtTA/+), Fgf9-OA (Fgf20Cre/+;ROSArtTA/+;TRE-Fgf9-IRES-eGfp), Fgf9-rescue
(Fgf20Cre/βgal;ROSArtTA/+;TRE-Fgf9-IRES-eGfp) mice as before and started Dox induction at
E13.5 until E15.0 (Fig 3). At E15.0, all of the Fgf20-het (4/4) and Fgf20-null (4/4) cochleae con-
tained Myo6-expressing HCs, while none of the Fgf9-OA (0/4) and Fgf9-rescue (0/4) cochleae
contained Myo6-expressing HCs (Fig 10C). This suggests that ectopic expression of FGF9 was
able to delay the onset of differentiation, even with the lack of endogenous FGF20. Despite this
delay in onset of differentiation, by P0, differentiation has apparently caught up in both
Fgf9-OA and Fgf9-rescue cochleae (Fig 3A).
Similar to a delay in prosensory specification, premature onset of differentiation narrows
the temporal buffer between the completion of specification and initiation of differentiation.
In the context of a slight delay in specification due to decreased Sox2 levels, premature differ-
entiation from the loss of Fgf20 can lead to an attempt at differentiation before specification in
the basal end of the cochlea. We propose that Sox2 and Fgf20 interact to regulate the bound-
aries of the temporal buffer, helping to ensure that differentiation begins after the completion
of specification (Fig 11).
Discussion
Fgfr1 is involved in prosensory specification and differentiation, while
Fgf20 is only involved in differentiation
Fgf20 and Fgfr1 are required for HC and SC development. Based on similarities in the pheno-
type caused by the loss of FGF20 and loss of FGFR1 signaling, FGF20 has been hypothesized as
the FGFR1 ligand during organ of Corti development [17–21]. However, the exact role of
FGF20/FGFR1 during organ of Corti development has been a topic of debate. We previously
reported that Fgf20-KO mice do not have defects in prosensory specification, and have a nor-
mally formed prosensory domain [21]. We further showed that FGF20 signaling is important
during the initiation stage of differentiation, and that Fgf20-KO cochleae have gaps in the dif-
ferentiated sensory epithelium filled with undifferentiated prosensory progenitors. However,
other studies have shown in vitro that FGF20 regulates prosensory specification via Sox2 [31]
and in vivo that FGFR1 is required for prosensory specification via Sox2 [19]. Here, we show,
using an in vivo rescue model, that ectopic FGF9 signaling is sufficient to rescue the Fgf20-KO
phenotype in a spatiotemporal pattern that matched the timing of initiation of differentiation
along the length of the cochlear duct. We conclude, therefore, that FGF20 is involved in differ-
entiation and is not necessary for prosensory specification.
Notably, the Fgf20-KO phenotype, in which two-thirds of OHCs fail to develop, is not as
severe as the Fgfr1-CKO phenotype, which lacks almost all OHCs as well as half of IHCs.
Potential explanations for this include differences in mouse genetic background, and the exis-
tence of a redundant FGF ligand(s). To rule out the former, we examine here Fgf20-KO and
Fgfr1-CKO mice on a similar genetic background, and replicated the difference in phenotype
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Fig 10. Fgf20-KO organ of Corti exhibits premature differentiation. (A) RNA in situ hybridization forHey1 andHey2 on sections through the
middle turn of E14.5 Fgf20+/- and Fgf20-/- cochleae. Samples are representative of n = (Hey1) 3, 3; (Hey2) 3, 3. (B, C) Immunofluorescence for Myo6
(red) on “mid-modiolar” sections through the (B) E14.5 Fgf20+/- and Fgf20-/- cochleae, and (C) E15.0 Fgf20-het (Fgf20Cre/+;ROSArtTA/+), Fgf20-null
(Fgf20Cre/βgal;ROSArtTA/+), Fgf9-OA (Fgf20Cre/+;ROSArtTA/+;TRE-Fgf9-IRES-eGfp), Fgf9-rescue (Fgf20Cre/βgal;ROSArtTA/+;TRE-Fgf9-IRES-eGfp)
cochleae (Dox from E13.5 to E15.0), with magnification. The number of cochleae containing Myo6-expressing cells out of the total number of
cochleae examined for each genotype are shown below each panel. Arrows indicate Myo6-expressing hair cells. DAPI, nuclei (blue). OS, outer
sulcus; PD, prosensory domain; KO, Kölliker’s organ. Scale bar, 100 μm.
https://doi.org/10.1371/journal.pgen.1008254.g010
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severity. We also replicated the decrease in Sox2 expression in the prosensory domain previ-
ously reported in Fgfr1-CKO mice [19]. We further reaffirmed that Sox2 expression in the pro-
sensory domain is not affected by the loss of Fgf20. This suggests that another FGF ligand
signaling through FGFR1 is required to maintain Sox2 expression during prosensory specifica-
tion. The identity of this ligand is currently unknown.
We hypothesized that the severity of the Fgfr1-CKO phenotype is due to decreased Sox2
expression causing disrupted prosensory specification and the loss of FGF20 signaling during
Fig 11. Sox2 and Fgf20 interact to modulate a temporal buffer between specification and differentiation. Model of the
roles of Sox2 and Fgf20 in organ of Corti development, which occurs in two stages: unspecified progenitors (tan shading)
undergo specification and cell cycle exit to become prosensory cells (green shading), which then differentiate into hair cells
and supporting cells (HCs & SCs; red shading). In wildtype cochleae, cell cycle exit (indicating completion of specification)
begins at the apex of the cochlea and proceeds basally. Afterwards, differentiation initiates at the mid-base of the cochlea and
proceeds basally and apically. The prosensory cells exist within a temporal buffer (green shading), defined as the time
between cell cycle exit and initiation of differentiation. In Sox2/Fgf20mutant cochleae, decrease in levels of Sox2 expression
in the developing cochlea leads to delayed prosensory specification and cell cycle exit (arrow 1), while loss of Fgf20 leads to
premature onset of differentiation at the basal and mid-basal cochlear turns (arrow 2) as well as delayed differentiation at the
apical turn (arrow 3). Loss of both Sox2 and Fgf20 leads to loss of the temporal buffer between specification and
differentiation towards the base of the cochlear duct, disrupting the development of HCs and SCs in the basal region
(crosshatch pattern).
https://doi.org/10.1371/journal.pgen.1008254.g011
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differentiation. Consistent with this hypothesis, the combination of Fgf20-/- and Sox2Ysb/Ysb
mutations phenocopied Fgfr1-CKO cochleae. The similarities in phenotype include approxi-
mately a 30% reduction in cochlear length and almost a complete loss of OHCs and SCs and
approximately a 50% loss of IHCs. Interestingly, the Fgf20-/-;Sox2Ysb/Ysb phenotype is also simi-
lar to the Sox2Ysb/- phenotype. We conclude that the Fgfr1-CKO, Fgf20-/-;Sox2Ysb/Ysb, and Sox2-
Ysb/- phenotypes likely lie along the same continuum, as these three genotypes all exhibited a
lack of Fgf20 expression or signaling and varying levels of Sox2 expression (Fig 9A). Fgf20-KO
cochleae, in which Sox2 expression was not affected, lies at the mild end of this continuum.
Interestingly, this continuum shows that in the absence of Fgf20 expression or signaling,
reductions in the level of Sox2most severely affected sensory epithelium development of the
cochlear base and the outer compartment. Moving from the Fgf20-KO (mild) end of the spec-
trum towards the Sox2Ysb/- (severe) end, increasing numbers of HCs and SCs are lost, preferen-
tially form the cochlear base and the outer compartment.
Importantly, while these results seem to suggest that the main function of FGFR1 signaling
during early stages of organ of Corti development is to regulate Sox2 expression, we have not
ruled out the potential for other functions of FGFR1 signaling. There are also notable differences
between the Fgfr1-CKO and Fgf20-/-;Sox2Ysb/Ysb phenotypes at P0. For instance, Fgfr1-CKO
cochleae have a slightly less severe OHC phenotype at the cochlear base relative to the apex, while
Fgf20-/-;Sox2Ysb/Ysb cochleae have a slightly more severe OHC phenotype at the base. We attribute
these phenotype differences to differences in the level of Sox2 expression and the timing of
decrease in Sox2 expression. However, they may be instead attributable to additional functions of
FGFR1 signaling not captured by the combination of Fgf20-/- and Sox2Ysb/Ysb mutations.
Foxg1Cre has been used in several studies to target the otic epithelium, including to condi-
tionally delete Fgfr1 [18–20]. One concern with Foxg1Cre is that it is a null allele [22]. Foxg1-
null mice have shortened cochlear length, although HC and SC differentiation did not appear
to be directly affected [32]. Previous work [33] and our results here showed that Foxg1 is not
haploinsufficient during cochlea development, as Foxg1Cre/+;Fgfr1flox/+ cochleae had very simi-
lar phenotypes to Fgfr1flox/- cochleae. Moreover, the use of the Six1enh21-Cre transgene, which
targets the otic epithelium in a similar spatiotemporal pattern as Foxg1Cre, to conditionally
delete Fgfr1 resulted in the same phenotype as Foxg1Cre/+;Fgfr1flox/- cochleae [19]. This
included the loss of almost all OHCs, loss of IHCs, and decreased prosensory Sox2 expression.
Therefore, the increased severity of Foxg1Cre/+;Fgfr1flox/- cochleae relative to Fgf20-/- cochleae is
likely not attributable Foxg1 haploinsufficiency.
Sox2 and Fgf20 interact to affect development towards the basal end of the
cochlea
We show here conclusive evidence that Sox2 and Fgf20 genetically interact during cochlea
development. Interestingly, HC and SC development towards the basal end of the cochlea is
more severely affected by the loss of Sox2 and Fgf20 and their interaction. While we hypothe-
size that Sox2 and Fgf20 are involved in distinct steps during organ of Corti development (pro-
sensory specification and differentiation, respectively), there is nevertheless potential for a
strong interaction. We propose that the timing of specification and differentiation define a
temporal buffer that normally prevents differentiation from initiating prior to the completion
of specification, and that Sox2 and Fgf20modulate the borders of this buffer. In a developmen-
tal pathway, the upstream event (specification) must occur prior to the downstream event (dif-
ferentiation). Therefore, loss of Sox2 and Fgf20 leading to delayed specification and premature
differentiation onset, respectively, disrupts the temporal buffer, especially towards the cochlear
base (Fig 11).
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Here, we use cell cycle exit in the prosensory domain (also known as the zone of non-prolif-
eration) as a marker for the completion of specification [3]. We hypothesize that prosensory
cells become specified and primed for differentiation upon withdrawal from the cell cycle. Pre-
vious studies showed that prosensory cells are indeed capable of differentiating into HCs and
SCs directly after cell cycle exit, even in the apex. When Shh was deleted from the spiral gan-
glion, differentiation began in the apex shortly after cell cycle exit and progressed towards the
base [5]. This suggests that specification occurs in an apex-to-base direction. It also suggests
that normally, SHH signaling prevents the apex from differentiating immediately after specifi-
cation. We cannot rule out, however, that specification occurs in the same direction as differ-
entiation (base-to-apex), independently of cell cycle exit. Such a scenario would still be
consistent with our model that a combination of delayed specification and premature onset of
differentiation accounts for the more severe basal phenotype in Fgf20/Sox2mutants.
The effect of loss of Fgf20 on the timing of differentiation is small. We estimate that the
onset of differentiation in Fgf20-KO cochleae is advanced by only around 0.5 days. By itself,
this effect does not lead to a more severe mid-basal or basal phenotype in Fgf20-KO cochleae.
However, we present evidence that on a sensitized genetic background causing delayed specifi-
cation, this small change in the timing of differentiation leads to a large defect in HC and SC
production towards the basal end of the cochleae. We propose that this at least partially
explains the interaction between Sox2 and Fgf20. Furthermore, the relative sparing of develop-
ment towards the apical end of Sox2Ysb/Ysb;Fgf20-/- cochleae, especially of IHCs, can be further
explained by a delay in differentiation at the apical end due to the loss of Fgf20. We do not
know why an apical-basal difference in timing of differentiation exists in Fgf20-KO cochleae.
Perhaps there is a delay in the apical progression of differentiation, or perhaps other factors
contribute to the differentiation of the apical end of the cochlea. Consistent with the latter, by
P7 in Fgf20-KO cochleae, the apical tip contains a full complement of IHCs and OHCs, unlike
the rest of the cochlea [21].
Importantly, the model that Sox2 and Fgf20 regulate the distinct processes of specification
and differentiation, respectively, is a simplified take on a complex developmental pathway for
the sake of addressing our specific question. While we show the potential for a Sox2 and Fgf20
interaction in modulating the temporal buffer between specification and differentiation, Sox2
also has known roles during HC and SC differentiation [13,15,34,35]. Therefore, the genetic
interaction may occur during differentiation as well. While interaction at this stage may
explain the preferential loss of outer compartment cells in Sox2 and Fgf20mutants, it does not
explain the selective loss of basal cochlear HCs and SCs. Therefore, we conclude that the Sox2
and Fgf20 interaction regulates the temporal buffer, with potential further interactions during
differentiation.
The Notch ligand Jagged1 (Jag1) is thought to be important for cochlear prosensory specifi-
cation via lateral induction [36–42]. Interestingly, Notch signaling has also been shown to be
upstream of both Fgf20 and Sox2 in the developing cochlea [31]. Conditional deletion of Jag1
or Rbpj, the major transcriptional effector of canonical Notch signaling, resulted in the loss of
HCs and SCs, particularly from the basal end of the cochlear duct, similar to Fgf20/Sox2
mutants. Unlike Fgf20/Sox2mutants, however, deletion of Jag1 or Rbpj led to preferential loss
of Sox2 and CDKN1B expression from the prosensory domain at the basal end of the cochlea
[37,39,43]. This suggests that Jag1-Notch signaling is required for prosensory specification,
especially towards the cochlear base. This likely accounts for the more severe basal phenotype
of Jag1 or Rbpjmutants. This same mechanism likely does not explain the more severe basal
phenotype of Fgf20/Sox2mutants, as Sox2 and CDKN1B expression was not more severely
reduced or absent in the cochlear base in these mice. Notably, not all studies agree that Jag1 or
Rbpj is required for Sox2 and CDKN1B expression or for prosensory specification [44]. More
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studies are required to further elucidate the functional relationship between Jag1/Notch, Fgf20,
and Sox2 during cochlea development.
Other genes that potentially interact with Fgf20 and Sox2 during cochlea development
includeMycn (N-Myc) andMycl (L-Myc). Interestingly, deletion ofMycn andMycl from the
cochlear epithelium results in accelerated cell cycle exit and delayed initiation of differentiation
[45], opposite to the effects of loss of Sox2 and Fgf20. Addressing potential interactions
between Sox2, Fgf20,Mycn, andMycl is another topic for future studies.
Outer compartment of the cochlear sensory epithelium is more sensitive to
the loss of Fgfr1, Fgf20, and Sox2 than the inner compartment
In all of the genotypes we observed in this study, the loss of outer compartment cells (i.e. OHCs)
was predominant. Only in the most severe cases in which almost all OHCs were missing, as seen
in Fgfr1-CKO, Fgf20-/-;Sox2Ysb/Ysb, and Sox2Ysb/- cochleae, were IHCs also lost. Similarly, reduction
in SC number always preferentially affected the outermost cells. This suggests that the organ of
Corti outer compartment is more sensitive to the loss of Fgfr1, Fgf20, and Sox2 than the inner
compartment. The combination of Fgf20- and Sox2Ysb alleles elegantly demonstrates this: as the
number of Fgf20- and Sox2Ysb alleles increased, the number of OHCs progressively decreased. In
the double homozygous mutants, the number of IHCs decreased as well. We also show here that
in Fgfr1-CKO and Fgf20-/-;Sox2Ysb/Ysb cochleae, there is a delay in cell cycle exit and completion of
specification, especially towards the abneural or outer side of the prosensory domain, which may
contribute to the more severe outer compartment phenotype. However, Fgf20-KO cochleae,
which also exhibit a more severe outer compartment phenotype, did not show a delay in specifica-
tion of the outer side of the prosensory domain, at least at the stage we examined. Further studies
are needed to elucidate differences in the timing of cell cycle exit and specification in the outer
and inner compartments, and how they may affect differentiation.
Previous studies noted that the dosage of Fgfr1 affects the degree of organ of Corti outer
compartment loss. In Fgfr1 hypomorphs with 80% reduction in transcription, only the third
row of OHCs were missing, while hypomorphs with 90% reduction had a slightly more severe
phenotype [20]. Therefore, Fgfr1 loss preferentially affects the outermost HCs. Other studies
suggested that the timing of Fgfr1 deletion is important in determining the degree of outer
compartment loss and level of Sox2 expression. When an earlier-expressed Cre driver (Six1-
enh21-Cre) was used to conditionally delete Fgfr1, almost all OHCs and some IHCs were lost,
with a 66% reduction in Sox2 expression at E14.5 [19]. When a later-expressed Cre driver
(Emx2Cre) was used, many more OHCs and IHCs remained, with only a 12% reduction in
Sox2 expression. Our results are consistent with both of these studies. We show that FGF20-in-
dependent FGFR1 signaling and Sox2 are required early, affecting both IHC and OHC devel-
opment, while FGF20-FGFR1 signaling is important during later stages, affecting only OHC
development.
Differentiation in the organ of Corti not only occurs in a basal-to-apical gradient, but also
in an orthogonal inner-to-outer gradient. That is, IHCs differentiate first, followed by each
sequential row of OHCs [46]. This wave of differentiation suggests that perhaps outer com-
partment HCs and SCs require a longer temporal buffer between specification and differentia-
tion. The genetic interaction between Sox2 and Fgf20 in modulating this temporal buffer,
therefore, could also account for the preferential loss of outer compartment HCs and SCs. We
hypothesize that the requirement for a longer temporal buffer may also be involved in deter-
mining OHC fate. In Fgf20+/-;Sox2+/- cochleae, there was a slight decrease in OHCs that was
compensated for by ectopic IHCs, suggesting a fate switch from OHCs into IHCs. Here, we
confirmed previous suggestions that Fgf20 regulatesHey1 and Hey2 to prevent premature
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differentiation in the developing organ of Corti [8,30]. Interestingly, inHey1/Hey2 double
knockout cochleae, there was a similar slight decrease in OHCs compensated for by ectopic
IHCs [30]. Furthermore, inner ear-specific deletion of either Smoothened or Neurod1, which
led to premature differentiation in the apical cochlear turn, also led to loss of OHCs and the
presence of ectopic IHCs at the apex [6,8]. These findings further support a model where tim-
ing of specification and differentiation affect IHC versus OHC fate, an interesting and impor-
tant topic for future studies.
Previously, we hypothesized that Fgf20 is strictly required for the differentiation of an outer
compartment progenitor [21]. However, data we present here show that Fgf20, on a sensitized,
Sox2 hypomorphic background, is also required for inner compartment differentiation. We
conclude that inner and outer compartment progenitors likely are not distinct populations.
Rather, all prosensory progenitors giving rise to the organ of Corti exist on an inner-to-outer
continuum. FGF20 signaling, in combination with other factors including Sox2, are required
for the proper development of all of these cells, though with varying sensitivities.
The relationship between Fgf20 and Hey1/Hey2 in regulating
differentiation is complex
We show in vivo that Fgf20 is upstream ofHey1 andHey2. Supporting this result, Fgfr1 has also
been shown in vivo to be upstream ofHey2 [19]. Interestingly, in explant studies, inhibition of
FGF signaling alone did not result in decreasedHey1/Hey2 expression or premature differentia-
tion [30]. However, FGF inhibition has been shown to rescue the overexpression ofHey1/Hey2
and the delay in differentiation induced by SHH signaling overactivation [8,30]. Notably, these
studies suggest that SHH signaling from the spiral ganglion regulates Fgf20 expression, which in
turn regulatesHey1 andHey2 expression to prevent premature differentiation in the organ of
Corti [5,8,30]. Our results here showing that Fgf20 regulatesHey1 andHey2 expression and tim-
ing of differentiation are mostly consistent with these studies. However,Hey1/Hey2 double
knockout cochleae do not exhibit a loss of OHCs to the extent of Fgf20-KO cochleae, suggesting
that other genes downstream of Fgf20 are important in prosensory cell differentiation (Fig 11).
Moreover, deletion of Fgf20 only led to premature differentiation at the basal and mid-basal
turns. Fgf20 deletion actually delayed differentiation in the apical end of the cochlea. Deletion of
Hey1/Hey2, contrarily, led to premature differentiation along the entire length of the cochlear
duct, although it is unclear howHey1/Hey2 loss affects the timing of apical differentiation
beyond E15.0 [30]. This suggests that other factors downstream of Fgf20 interact withHey1/
Hey2 to regulate the timing of differentiation. Perhaps these same genes contribute to the loss of
OHCs in Fgf20-KO cochleae.Mekk4, which has been shown to be downstream of Fgf20 and
necessary for OHC differentiation [47] could be one of these genes. Identifying other factors
downstream of Fgf20 will be a topic of future studies.
Materials and methods
Ethics statement
All studies performed were in accordance with the Institutional Animal Care and Use Com-
mittee at Washington University in St. Louis (protocol #20160113) and University of Nebraska
Medical Center (protocol #16-004-02 and 16-005-02).
Mice
Mice were group housed with littermates, in breeding pairs, or in a breeding harem (2 females
to 1 male), with food and water provided ad libitum.
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For timed-pregnancy experiments, embryonic day 0.5 (E0.5) was assigned as noon of the
day the vaginal plug was found. For postnatal experiments, postnatal day 0 (P0) was deter-
mined as the day of birth.
Mice were of mixed sexes and maintained on a mixed C57BL/6J x 129X1/SvJ genetic back-
ground. All mice were backcrossed at least three generations onto this background. The fol-
lowing mouse lines were used:
• Fgf20Cre (Fgf20-; MGI:5751785): knockin allele containing a sequence encoding a GFP-Cre
fusion protein replacing exon 1 of Fgf20, resulting in a null mutation [18].
• Fgf20βgal (RRID:MGI:5425887): knockin allele containing a sequence encoding β-galactosi-
dase (βgal) replacing exon 1 of Fgf20, resulting in a null mutation [21].
• Foxg1Cre (RRID:IMSR_JAX:004337): knockin allele containing a sequence encoding Cre
fused in-frame downstream of the first 13 codons, resulting in a null mutation [22].
• Fgfr1flox (RRID:IMSR_CMMR:0268): allele containing loxP sequences flanking exons 8
through 15 of Fgfr1. Upon Cre-mediated recombination, produces a null mutation [48]
• Fgfr1-: null allele generated by combining Fgfr1flox with Sox2Cre (RRID:IMSR_JAX:004783)
[49] to delete Fgfr1 from the epiblast.
• ROSArtTA (RRID:IMSR_JAX:005670): knockin allele containing a loxP-Stop-loxP sequence
followed by a sequence encoding rtTA-IRES-eGFP, targeted to the ubiquitously expressed
ROSA26 locus. Upon Cre-mediated recombination, reverse tetracycline transactivator
(rtTA) and eGFP are expressed [25].
• TRE-Fgf9-IRES-eGfp (MGI:5538516): transgene containing seven tetracycline-inducible
regulatory elements driving the expression of FGF9-IRES-eGFP [26].
• Sox2Ysb (RRID:IMSR_EM:05015): Inner ear specific Sox2 hypomorphic allele resulting from
a random insertion of a transgene in chromosome 3, likely interfering with tissue-specific
Sox2 regulatory elements [11].
• Sox2-: null allele generated by combining Sox2flox (RRID:IMSR_JAX:013093) [50] with
Sox2Cre to delete Sox2 from the epiblast.
Doxycycline induction
Pregnant dams were starved overnight the night before initiation of Dox induction and fed
Dox Diet, Grain-Based Doxycycline, 200 mg/kg (S3888, Bio-Serv, Flemington, NJ) ad libitum
starting at noon on the start date of Dox induction. On the stop date of Dox induction, Dox
Diet was replaced with regular mouse chow at noon.
Sample preparation and sectioning
For whole mount cochleae, inner ears were dissected out of P0 pups and fixed in 4% PFA in
PBS overnight at 4˚C with gentle agitation. Samples were then washed x3 in PBS. Cochleae
were dissected away from the vestibule, otic capsule, and periotic mesenchyme with Dumont
#55 Forceps (RS-5010, Roboz, Gaithersburg, MD). The roof of the cochlear duct was opened
up by dissecting away the stria vascularis and Reissner’s membrane; tectorial membrane was
removed to expose hair and supporting cells.
For sectioning, heads from E14.5 embryos were fixed in 4% PFA in PBS overnight at 4˚C
with gentle agitation. Samples were then washed x3 in PBS and cryoprotected in 15% sucrose
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in PBS overnight and then in 30% sucrose in PBS overnight. Samples were embedded in Tis-
sue-Tek O.C.T. compound (4583, VWR International, Radnor, PA) and frozen on dry ice.
Serial horizontal sections through base of the head were cut at 12 μm with a cryostat, dried at
room temperature, and stored at -80˚C until use.
RNA in situ hybridization
Probe preparation: mouse cDNA plasmids containing the following inserts were used to make
RNA in situ probes, and were cut and transcribed with the indicated restriction enzyme (New
England Biolabs, Ipswich, MA) and RNA polymerase (New England Biolabs, Ipswich, MA):
Fgfr1 transmembrane domain (pBluescriptKS-Fgfr1TM, 325 bp, HincII, T7, gift of K. Peters),
Fgf20 (pGEMT-Fgf20, 653 bp, NcoI, Sp6), Sox2 (pBluescriptSK-Sox2, 750 bp, AccI, T3, gift of A.
Kiernan), Etv4 (pGEM-Etv4, ~2300 bp, ApaI, Sp6, gift of G. Martin), Etv5 (pBluescriptSK-Etv5,
~4000 bp, HindIII, T3, gift of G. Martin),Hey1 (pT7T3D-Hey1 [IMAGE clone #478014], 343
bp, EcoRI, T3, gift of S. Rentschler),Hey2 (pCMVSPORT6-Hey2 [IMAGE clone #5374813], 819
bp, EcoRI, T7, gift of S. Rentschler). Restriction digest and in vitro transcription were done
according to manufacturer’s instructions, with DIG RNA Labeling Mix (11277073910, Sigma-
Aldrich, St. Louis, MO). After treatment with RNase-free DNase I (04716728001, Sigma-
Aldrich, St. Louis, MO) for 15 min at 37˚C, probes were hydrolyzed in hydrolysis buffer (40
mM NaHCO3, 60 mM Na2CO3) at 60˚C for up to 30 min, depending on probe size.
Frozen section in situ hybridization: frozen slides were warmed for 20 min at room temper-
ature and then 5 min at 50˚C on a slide warmer. Sections were fixed in 4% PFA in PBS for 20
min at room temperature, washed x2 in PBS and treated with pre-warmed 10 μg/ml Proteinase
K (03115828001, Sigma-Aldrich, St. Louis, MO) in PBS for 7 min at 37˚C. Sections were then
fixed in 4% PFA in PBS for 15 min at room temperature, washed x2 in PBS, acetylated in
0.25% acetic anhydrate in 0.1M Triethanolamine, pH 8.0, for 10 min, and washed again in
PBS. Sections were then placed in pre-warmed hybridization buffer (50% formamide, 5x SSC
buffer, 5 mM EDTA, 50 μg/ml yeast tRNA) for 3 h at 60˚C in humidified chamber for prehy-
bridization. Sections were then hybridized in 10 μg/ml probe/hybridization buffer overnight
(12–16 h) at 60˚C. The next day, sections were washed in 1x SSC for 10 min at 60˚C, followed
by 1.5x SSC for 10 min at 60˚C, 2x SSC for 20 min at 37˚C x2, and 0.2x SSC for 30 min at 60˚C
x2. Sections were then washed in KTBT (0.1 M Tris, pH 7.5, 0.15 M NaCl, 5 mM KCl, 0.1%
Triton X-100) at room temperature and blocked in KTBT + 20% sheep serum + 2% Blocking
Reagent (11096176001, Sigma-Aldrich, St. Louis, MO) for 4 h. Blocking Reagent was dissolved
in 100 mM Maleic acid, 150 mM NaCl, pH 7.5. Sections were then incubated in sheep anti-
Digoxigenin-AP, Fab fragments (1:1000, 11093274910, Sigma-Aldrich, St. Louis, MO) in
KTBT + 20% sheep serum + 2% Blocking Reagent overnight at 4˚C. Sections were then washed
x3 in KTBT for 30 min at room temperature, and then washed x2 in NTMT (0.1 M Tris, pH
9.5, 0.1 M NaCl, 50 mM MgCl2, 0.1% Tween 20) for 15 min. Sections were next incubated in
NTMT + 1:200 NBT/BCIP Stock Solution (11681451001, Sigma-Aldrich, St. Louis, MO) in the
dark at room temperature until color appeared. Sections were then washed in PBS, post-fixed
in 4% PFA in PBS for 15 min and washed x2 in PBS. Finally, sections were dehydrated in 30%
and then 70% methanol, 5 min each, followed by 100% methanol for 15 min. Sections were
then rehydrated in 70% and 30% methanol and then PBS, 5 min each, and mounted in 95%
glycerol.
Immunofluorescence
Whole mount: cochleae were incubated in PBS + 0.5% Tween-20 (PBSTw) for 1 h to permea-
bilize. Cochleae were then blocked using PBSTw + 5% donkey serum for 1 h and then
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incubated in PBSTw + 1% donkey serum with the primary antibody overnight at 4˚C.
Cochleae were then washed x3 in PBS and incubated in PBS + 1% Tween-20 with the second-
ary antibody. After wash in PBS x3, cochleae were mounted in 95% glycerol with the sensory
epithelium facing up.
Frozen slides were warmed for 30 min at room temperature and washed in PBS before
incubating in PBS + 0.5% Triton X-100 (PBST) for 1 h to permeabilize the tissue. Sections
were then blocked using in PBST + 5% donkey serum for 1 h and then incubated in PBST +
1% donkey serum with the primary antibody overnight at 4˚C in a humidified chamber. Sec-
tions were then washed x3 in PBS and incubated in PBS + 1% Triton X-100 with the secondary
antibody. After wash in PBS x3, slides were mounted in VectaShield antifade mounting
medium with DAPI (H-1200, Vector Labs, Burlingame, CA).
Primary antibodies: rabbit polyclonal anti-P75NTR (1:300, AB1554, EMD Millipore), rabbit
polyclonal anti-Prox1 (1:1000, ABN278, EMD Millipore), goat polyclonal anti-Sox2 (1:200, sc-
17320, Santa Cruz Biotechnology), rabbit polyclonal anti-p27Kip1 (1:50, RB-9019-P, Neomar-
kers), rabbit polyclonal anti-Ki67 (1:200, ab15580, Abcam), rabbit polyclonal anti-Myo6
(1:100, sc-50461, Santa Cruz Biotechnology). Secondary antibodies: donkey polyclonal anti-
Rabbit IgG, Alexa Fluor 488 (1:500, A-21206, Thermo-Fisher Scientific), donkey polyclonal
anti-Goat IgG, Alexa Fluor 555 (1:500, A-21432, Thermo-Fisher Scientific), goat polyclonal
anti-Rabbit IgG, Alexa Fluor 555 (1:500, A-21428, Thermo-Fisher Scientific), donkey poly-
clonal anti-Rabbit IgG, Alexa Fluor 594 (1:500, A-21207, Thermo-Fisher Scientific). Other
compounds: Alexa Fluor 488-conjugated Phalloidin (1:50, A12379, Invitrogen).
Cell proliferation assay
EdU (E10187, Thermo-Fisher Scientific, Waltham, MA) was injected i.p. into pregnant dams
at 100 μg per gram body weight. Embryos were harvested at 1 h after injection. EdU was
detected using the Click-iT EdU Alexa Fluor 488 kit (C10337, Thermo-Fisher Scientific, Wal-
tham, MA) according to manufacturer’s instructions.
Imaging
Brightfield microscopy was done using a Hamamatsu NanoZoomer slide scanning system
with a 20x objective. Images were processed with the NanoZoomer Digital Pathology (NDP.
view2) software.
Fluorescent microscopy was done using a Zeiss LSM 700 confocal or Zeiss Axio Imager Z1
with Apotome 2, with z-stack step-size determined based on objective lens type (10x or 20x),
as recommended by the ZEN software (around 1 μm). Fluorescent images shown are maxi-
mum projections. Low magnification fluorescent images shown of the whole cochlear duct
required stitching together, by hand, several images. Images were processed with ImageJ
(imagej.nih.gov).
Quantification
Measurements and cell quantification (using the Cell Counter plugin by Kurt De Vos) were
done using ImageJ. Total cochlear duct length was defined as the length from the very base of
the cochlea to the very tip of the apex, along the tunnel of Corti. Hair cells were identified via
Phalloidin, which binds to F-actin [51]. Supporting cells (SCs, including pillar cells and Dei-
ters’ cells) were identified based on positive labeling with both Prox1 [52] and Sox2 [10]. Inner
hair cells (IHCs) were differentiated from outer hair cells (OHCs) based on their neural/
abneural location, respectively, relative to p75NTR-expressing inner pillar cells [53]. For total
cell counts, IHCs, OHCs, and SCs were counted along the entire length of the cochlea. Total
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cell counts were also normalized to cochlear length and presented as cell count per 100 μm of
cochlea (e.g. IHCs/100 μm). For cell quantification at the basal, middle, and apical turns of the
cochlea, the cochlear duct was evenly divided into thirds, and total IHCs, OHCs, and SCs were
quantified for each third and normalized to length. For the Fgf9-rescue experiments in Fig 3,
IHCs, OHCs, and SCs from at least 300 μm regions of the basal (10%), middle (40%), and api-
cal (70%) turns of the cochleae were counted and normalized to 100 μm along the length of the
cochlear duct.
In Sox2Ysb/- cochleae, p75NTR expression was mostly absent, resulting in sensory islands
without p75NTR-expressing inner pillar cells. In these cochleae, HCs not associated with inner
pillar cells were presumed to be IHCs during quantification. When a curved line was drawn
connecting the p75NTR islands along the organ of Corti, these presumed IHCs were always
neural (inner) to that line.
Statistical analysis and plotting
All figures were made in Canvas X (ACD systems). Data analysis was performed using the
Python programming language (python.org) in Jupyter Notebook (jupyter.org) with the fol-
lowing libraries: Pandas (pandas.pydata.org), NumPy (numpy.org) and SciPy (scipy.org). Plot-
ting was done using the Matplotlib library (matplotlib.org). Statistics (t-test, Mann-Whitney U
test, one-way ANOVA, two-way ANOVA, and Fisher’s exact test) were performed using the
SciPy module Stats; Tukey’s HSD was performed using the Statsmodels package (statsmodels.
org). All comparisons of two means were performed using two-tailed, unpaired Student’s t-
test. For comparisons of more than two means, one-way ANOVA was used, except in Fig 8
and S7 Fig, where two-way ANOVA was used, with the factors being Fgf20 (levels: Fgf20+/+,
Fgf20+/-, Fgf20-/-) and Sox2 (levels: Sox2+/+, Sox2Ysb/+, Sox2Ysb/Ysb) gene dosage. For significant
ANOVA results at α = 0.05, Tukey’s HSD was performed for post-hoc pair-wise analysis. In all
cases, p< 0.05 was considered statistically significant. All statistical details can be found in the
figures and figure legends. In all cases, each sample (each data point in graphs) represents one
animal. Based on similar previous studies, a sample size of 3–5 was determined to be appropri-
ate for our experiments. Error bars represent mean ± standard deviation (SD). All numerical
data underlying graphs can be found in S1 File. For qualitative comparisons (comparing
expression via immunofluorescence or RNA in situ hybridization), at least three samples were
examined per genotype. All images shown are representative.
Evaluation of onset of Myo6-expressing cells (Fig 10B and 10C): 3 or 4 serial sections
through the entire cochleae were immunostained for Myo6 and evaluated, blinded to geno-
type, for the presence of Myo6-expressing cells. E14.5 embryos were further stage-matched
based on interdigital webbing of the hindlimb (at E14.5, roughly half of the hindlimb interdigi-
tal webbing is still present). Of the 34 embryos at E14.5, 3 were removed from analysis due to
lack of or minimal hindlimb interdigital webbing (too old relative to the other embryos).
Supporting information
S1 Fig. Supplement to Fig 1. (A-C) Quantification of length-normalized number of (A) inner
hair cells (IHCs/100 μm), (B) outer hair cells (OHCs/100 μm), and (C) supporting cells (SCs/
100 μm) in the basal, middle, and apical turns of P0 cochleae from Fgf20+/-, Fgf20-/-, and
Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;Fgfr1flox/+, and Foxg1Cre/+;Fgfr1flox/- mice. Fgf20+/- and Fgf20-/-
cochleae were analyzed by unpaired Student’s t test; Fgfr1flox/+, Fgfr1flox/-, Foxg1Cre/+;Fgfr1flox/+,
and Foxg1Cre/+;Fgfr1flox/- cochleae were analyzed by one-way ANOVA. P values shown are
from the t test and ANOVA. � indicates p< 0.05 from Student’s t test or Tukey’s HSD
(ANOVA post-hoc); n.s., not significant. Error bars, mean ± SD. n = (A, B) 3, 4, 4, 3, 3, 6; (C)
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4, 5, 3, 3, 4, 4. (D) Schematic showing the positions of basal, middle, and apical turns along the
cochlear duct. Apical tip refers to the apical end of the cochlea. (E) Whole mount cochlea from
P0 Fgf20+/-, Fgf20-/-, and Foxg1Cre/+;Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/- mice showing immunofluo-
rescence for phalloidin (green) and p75NTR (red) at the apical tip of the cochlea. T, towards
the tip. Scale bar, 100 μm. Samples are representative of n = 3, 4, 3, 6.
(TIF)
S2 Fig. Supplement to Fig 2. (A, B) Sections through the middle turn of E14.5 cochlear ducts
from Fgf20+/-, Fgf20-/-, and Foxg1Cre/+;Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/- mice. Scale bar, 100 μm.
Refer to schematic below. OS, outer sulcus; PD, prosensory domain; KO, Kölliker’s organ. (A)
RNA in situ hybridization for Etv4 and Etv5. The two brackets indicate Etv4/5 expression in
the outer sulcus (OS, left) and prosensory domain (PD, right; lost in Fgf20-/- and Foxg1Cre/+;
Fgfr1flox/- cochleae). Samples are representative of n = (Etv4) 3, 3, 4, 4; (Etv5) 3, 3, 4, 4. (B)
EdU-incorporation (green). Dashed region indicates Kölliker’s organ (KO). DAPI, nuclei
(blue). Samples are representative of n = 3, 3, 3, 3.
(TIF)
S3 Fig. Supplement to Fig 3. Quantification of length-normalized number of inner hair cells
(IHCs/100 μm), outer hair cells (OHCs/100 μm), and supporting cells (SCs/100 μm) overall
(along the entire cochlea; top three graphs) and in the basal, middle, and apical turns (bottom
three graphs) of P0 cochleae from Fgf20+/-;ROSArtTA (Fgf20-het), Fgf20+/-;ROSArtTA; TRE-Fg-
f9-IRES-eGfp (Fgf9-OA), Fgf20-/-;ROSArtTA (Fgf20-null), and Fgf20-/-;ROSArtTA; TRE-Fgf9-IRES-
eGfp (Fgf9-rescue) mice. Dox regimens: E13.5-E15.5, E13.5, E14.5, or E15.5 (see box for sche-
matic showing the Dox diet start and stop times for each regimen). P values shown are from one-
way ANOVA. � indicates p< 0.05 from Tukey’s HSD (ANOVA post-hoc); n.s., not significant.
Error bars, mean ± SD. Summarized in Fig 3C. Sample sizes are indicated below the graphs.
(TIF)
S4 Fig. Supplement to Fig 4. (A-C) Quantification of length-normalized number of (A) inner
hair cells (IHCs/100 μm), (B) outer hair cells (OHCs/100 μm), and (C) supporting cells (SCs/
100 μm) in the basal, middle, and apical turns of P0 cochleae from Sox2+/+, Sox2Ysb/+, Sox2Ysb/
Ysb, and Sox2Ysb/- mice. P values shown are from one-way ANOVA. � indicates p< 0.05 from
Tukey’s HSD (ANOVA post-hoc); n.s., not significant. Error bars, mean ± SD. n = (A, B) 4, 4,
4, 4; (C) 4, 5, 3, 3. (D) Whole mount cochlea from P0 Sox2Ysb/- mice showing presence of inner
and outer hair cells (phalloidin/p75NTR) and supporting cells (Prox1/Sox2, in a different
cochlea) at the basal tip. Schematic shows the location of sensory epithelium at the apical turn
and basal tip of Sox2Ysb/- cochleae. Scale bar, 1 mm (whole), 100 μm (basal tip).
(TIF)
S5 Fig. Supplement to Fig 5. (A, B) Immunofluorescence for (A) Sox2 (red) and (B)
CKDN1B (green) in sections through the basal, middle, and apical turns of E14.5 Sox2Ysb/+
and Sox2Ysb/- cochleae. Samples are representative of n = (A) 5, 6; (B) 3, 3. (C) Immunofluores-
cence for Ki67 (red) on serial “mid-modiolar” sections through the E14.5 and E15.5 Sox2Ysb/+
and Sox2Ysb/- cochleae. Brackets indicate prosensory domain. Nine sections through the length
of the cochlear duct are labeled. See whole mount cochlear duct schematic (lower left) for rela-
tive positions of the sections. Samples are representative of n = (E14.5) 3, 3; (E15.5) 3, 3. DAPI,
nuclei (blue). Scale bar, 100 μm.
(TIF)
S6 Fig. Supplement to Fig 6. (A) Immunofluorescence for Ki67 (red) and EdU-incorporation
(green) in sections through the basal turn of E14.5 Sox2Ysb/+ and Sox2Ysb/- cochleae. Cochlear
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epithelium is outlined. Bracket indicates the prosensory domain (PD). Samples are representa-
tive of n = 3, 3. (B) Serial sections (1–6) through the duct of E14.5 Fgf20+/-, Fgf20-/-, and
Foxg1Cre/+;Fgfr1flox/+, Foxg1Cre/+;Fgfr1flox/- cochleae. Immunofluorescence for Ki67 (red) and
DAPI (nuclei, cyan). Cochlear epithelium is outlined. Bracket indicates prosensory domain. �
indicates shift of prosensory nuclei away from the luminal surface of the epithelium. N, neural
side. Samples are representative of n = 6, 6, 5, 5. Whole mount cochlear duct schematics
show relative positions of the serial sections and progression of cell cycle exit (green arrow).
(C) EdU-incorporation (green) in sections through the middle turn of E14.5 Sox2Ysb/+ and
Sox2Ysb/- cochleae. Dashed region indicates Kölliker’s organ (KO). Bracket indicates part of
Kölliker’s organ without EdU-incorporating cells in Sox2Ysb/- cochleae. Samples are represen-
tative of n = 3, 3. OS, outer sulcus; PD, prosensory domain; KO, Kölliker’s organ. DAPI, nuclei
(blue). Scale bar, 100 μm.
(TIF)
S7 Fig. Supplement to Figs 7 and 8. (A) P values from two-way ANOVA analyzing the quan-
tification in (B-D). The two factors analyzed are Fgf20 (Fgf20+/+, Fgf20+/-, Fgf20-/-) and Sox2
(Sox2+/+, Sox2Ysb/+, Sox2Ysb/Ysb) gene dosage. A p value < 0.05 (yellow highlight) for Fgf20 or
Sox2 indicates that the particular factor (independent variable) has a statistically significant
effect on the measurement (dependent variable). Whereas a p value< 0.05 for Interaction
indicates a statistically significant interaction between the effects of the two factors on the mea-
surement. (B-D) Quantification of length-normalized number of (B) inner hair cells (IHCs/
100 μm), (C) outer hair cells (OHCs/100 μm), and (D) supporting cells (SCs/100 μm) in the
basal, middle, and apical turns of P0 cochleae from Fgf20+/+;Sox2+/+, Fgf20+/+;Sox2Ysb/+,
Fgf20+/-;Sox2+/+, Fgf20+/-;Sox2Ysb/+, Fgf20+/+;Sox2Ysb/Ysb, Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2+/+,
Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb mice. Error bars, mean ± SD. n = (B, C) 5, 5, 5, 4, 4,
4, 4, 5, 6; (D) 4, 5, 3, 3, 3, 3, 3, 5, 5.
(TIF)
S8 Fig. Supplement to Figs 7 and 8. Results from post-hoc Tukey’s HSD analyzing the quanti-
fication results in (B-D). Letters (I, O, S; representing each measurement in S7B–S7D Fig)
indicate a statistically significant decrease (p< 0.05) when comparing the row genotype
against the column genotype. L, cochlear length; I, IHCs/100 μm; O, OHCs/100 μm; S, SCs/
100 μm.
(TIF)
S9 Fig. Interaction between the Fgf20 and Sox2 null alleles. (A) Whole mount cochlea from
P0 Fgf20+/+;Sox2+/+, Fgf20+/-;Sox2+/+, Fgf20+/+;Sox2+/-, and Fgf20+/-;Sox2+/- mice showing
inner and outer hair cells (phalloidin, green) separated by inner pillar cells (p75NTR, red).
Magnifications show the basal, middle, and apical turns of the cochlea. Scale bar, 100 μm
(magnifications), 1 mm (whole); arrowheads indicate ectopic inner hair cells. (B-F) Quantifi-
cation of (B) cochlear duct length, (C) total inner hair cells (IHCs) and IHCs per 100 μm of the
cochlear duct, (D) total outer hair cells (OHCs) and OHCs per 100 μm, and (E) IHCs/100 μm
and (F) OHCs/100 μm in the basal, middle, and apical turns at P0. P values shown are from
one-way ANOVA. � indicates p< 0.05 from Tukey’s HSD (ANOVA post-hoc); n.s., not signif-
icant. Error bars, mean ± SD. n = 5, 3, 4, 6.
(TIF)
S10 Fig. Supplement to Fig 9. (A, B) Immunofluorescence for (A) Sox2 (red) and (B)
CDKN1B (green) in sections through the basal, middle, and apical turns of E14.5 Fgf20+/-;
Sox2Ysb/+, Fgf20-/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb, and Fgf20-/-;Sox2Ysb/Ysb cochleae. Samples are
representative of n = (A) 4, 4, 4, 4; (B) 5, 5, 5, 5. (C) EdU-incorporation (green) in sections
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through the middle turn of E14.5 Fgf20+/-;Sox2Ysb/+, Fgf20-/-;Sox2Ysb/+, Fgf20+/-;Sox2Ysb/Ysb, and
Fgf20-/-;Sox2Ysb/Ysb cochleae. Dashed region indicates Kölliker’s organ (KO). Samples are rep-
resentative of n = 3, 3, 3, 3. (D) Serial sections (1–6) through the duct of E14.5 Fgf20+/-;Sox2Ysb/
+, Fgf20+/-;Sox2Ysb/Ysb, Fgf20-/-;Sox2Ysb/+, and Fgf20-/-;Sox2Ysb/Ysb cochleae. Immunofluores-
cence for Ki67 (red) and DAPI (nuclei, cyan). Cochlear epithelium is outlined. Bracket indi-
cates prosensory domain. � indicates shift of prosensory nuclei away from the luminal surface
of the epithelium. N, neural side. Samples are representative of n = 4, 4, 4, 4. Whole mount
cochlear duct schematics show relative positions of the serial sections and progression of cell
cycle exit (green arrow). Note: unlike in Fig 7, the placement of images from Fgf20-/-;Sox2Ysb/+
and Fgf20+/-;Sox2Ysb/Ysb cochleae have been switched to facilitate comparison. OS, outer sulcus;
PD, prosensory domain; KO, Kölliker’s organ. DAPI, nuclei (blue). Scale bar, 100 μm.
(TIF)
S1 File. Numerical data underlying graphs.
(XLSX)
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